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Perkinsus marinus is a marine protozoan responsible for “Dermo” disease in the eastern oyster species, 
Crassostrea virginica.  P. marinus has been detected along the Atlantic Coast of the United States and 
Mexico. In laboratory studies, many parasites need to be maintained in vivo, which complicates the study 
of the organism. However, In vitro cell culture for P. marinus at a scale of 1 mL was established in 1993 by 
several groups with the 1995 optimization (Gauthier & Vasta, 1993, 1995) considered the gold standard 
for small scale growth of this species. In addition to its importance as a parasite of an important food 
source, P. marinus is notable among easily cultured microbes in its ability to produce, fold and excrete 
very large, complex proteins. Such proteins could potentially be used for therapeutic applications, such as 
development of vaccines.  
In order to be useful as an organism to produce vaccines, we need to learn how to grow the organism at 
larger scale. Transitioning the growth procedures from small culture vials to tenfold larger bioreactors is 
a first step towards achieving this scale up. Growing P. marinus in a bioreactor introduces new production 
variables and challenges, such as: aeration, pH control, temperature control, and cost of media. In this 
study we developed methods and procedures to grow P. marinus in bioreactors and have also developed 
a lower cost growth medium that reduced the cost of growth medium ingredients by about 60%. Higher 
 
 
order cell culture comes with expensive media components, most notably fetal bovine serum (FBS), which 
provides essential growth factors and cytokines for growing cells. A promising replacement for FBS was 
found to be chicken serum (CS). It has the potential to provide growth factors and cytokines at a much 
lower cost than FBS.  
SuperPro Designer v10 (Intelligen, Inc., Scotch Plains, New Jersey) is a process simulator software 
designed to analyze the techno-economics of commercial-scale bioprocesses. SuperPro Designer v10 
was used to translate the experimental fermentation data from this study into a process model that 
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Historical Information  
Perkinsus marinus is an intracellular parasite that causes “Dermo” disease in the eastern oyster 
species, Crassostrea virginica, and has been detected along the Atlantic and Gulf coasts of the USA 
(Fernández Robledo et al., 2018)  and Mexico (Ford, 1996). P. marinus was first described by Mackin et al. 
in 1950. Originally, P. marinus was named as Dermocystidium marinum, and placed in the phylum 
Apicomplexa. (Mackin, Owen, & Collier, 1950). In 1978, D. marinum was reclassified because the 
zoospores differed from all other apicomplexans and was renamed Perkinsus marinus, but remained in 
the Apicomplexa phylum (Levine, 1978). In 1982, Vivier argued that P. marinus was more closely related 
to dinoflagellates (Vivier, 1982). In 1997, it was argued that P. marinus was no longer to be included in the 
Apicomplexa phylum based on data from a non-coding structural gene. Instead, P. marinus was thought 
to be more closely related to the dinoflagellates, (Siddall, Reece, Graves, & Burreson, 1997) confirming 
Vivier’s thoughts.  In 1999, P. marinus was placed a in a new phylum, Perkinsozoa, which bridges the 
evolutionary gap between Apicomplexa and Dinoflagellates (Norén, Moestrup, & Rehnstam-Holm, 1999).  
The Perkinsozoa phylum is an exclusively parasitic group with 3 families: Perkinsidae (infects 
shellfish), Xcellidae (infects fish), and Parviluciferaceae (infects dinoflagellates) and seven genera. The 
Perkinsozoa phylum also includes parasites which have been attributed to mass mortalities in amphibian 
populations in the United States (Gleason, Chambouvet, Sullivan, Lilje, & Rowley, 2014). Perkinsea 
hypnospore-like and trophozoite-like organisms were found were found in the liver, kidney, spleen and 
pancreas of frogs (Isidoro-Ayza, Grear, & Chambouvet, 2019). The Parviluciferaceae includes 4 genera: 
Dinovorax, Snorkelia, Tuberlatum, and Parvilucifera. The Dinovorax, Snorkelia (Reñé, Alacid, Ferrera, & 
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Garcés, 2017), Tuberlatum (Jeon & Park, 2019) genera only includes one species per genus. Parvilucifera 
has the most species with 4 (P. infectans, P. rostrata, P. corolla, and P.multicavata) (Jeon & Park, 2020).   
 
Life Cycle of Perkinsus marinus 
P. marinus has three main life stages: trophozoite, hypnospore, and zoospores. The trophozoite 
stage occurs in the tissues of the live host. P. marinus, as a mature trophozoite, has been described as 
having a very large vacuole containing an inclusion body, which pushes the nucleus to one side of the cell 
(Mackin et al., 1950). Using an electron microscope, it can be seen that immature trophozoites contain: 
mitochondria with tubular cristae, smooth endoplasmic reticulum, a nucleus with a small nucleolus, virus-
like particles and two centrioles (Perkins, 1996) (Figure 1). Proliferation within the host involves the 
trophozoite undergoing cycles of karyokinesis followed by cytokinesis, which will which will yield up to 
32/64 daughter cells. The cell wall will then rupture allowing the daughter cells, or immature trophozoites, 
to be released. The immature trophozoites will then gradually begin to grow and become mature 






Hypnospore has been observed when P. marinus were grown in fluid thioglycollate medium. It is 
characterized by a thick cell wall growing around the trophozoite. When hypnospores are isolated and 
returned to sea water, they will begin zoosporulation. It is believed that the hypnospore stage may be the 
dormant stage, which will allow P. marinus to live in unfavorable conditions (Perkins, 1996), such as 
extreme salinity and extreme temperatures. (Queiroga, Marques-Santos, De Medeiros, & Da Silva, 2016)   
 Zoospores are formed within the cell wall and are ellipsoidal in shape with normally two flagella, 
sometimes there is only one flagellum present. Zoospores contain a U-shaped large vacuole, a single Golgi 
body located next to the nucleus, one mitochondrion, lipid droplets, and a nucleus with well-defined 
Figure 1 Diagram of Perkinsus marinus with selected features highlighted. 
Created with BioRender.com 
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heterochromatin (Perkins, 1996). Zoospores will exit the zoosporangia through a single discharge tube, 
while occasionally, there will be two discharge tubes (Montes, Durfort, & García-Valero, 2005; Sunila, 
Hamilton, & Duncan, 2001) (Figure 2). However, zoosporulation has not been observed in vitro for 
P.marinus (Casas & La Peyre, 2013). 
 In the lab, we work with the trophozoite stage of growth (Figure 3).  
 





Figure 3 Diagram of Trophozoite Life Cycle of Perkinsus marinus. Created with BioRender.com 
Genetic Modification  
It has been shown that p. marinus, in the trophozoite stage of growth, is able to undergo genetic 
modification. Using a highly expressed gene, MOE, P. marinus is able to be transfected via a plasmid 
(Fernández-Robledo, Lin, & Vasta, 2008). Using an upgraded version of the plasmid, P. marinus was able 
to be transfected with two genes, MSP8 and HAP2, from Plasmodium berghei. Both genes are currently 
being considered as candidates for malaria vaccine development (Cold, Vasta, & Robledo, 2016).     
Sakamoto et al. improved the selection process for genetic modification. They discovered that 
puromycin and blasticidin S are potent growth inhibitors against P. marinus (Sakamoto et al., 2019; 
Sakamoto, Kita, & Matsuzaki, 2016). Using both drugs allow for a more efficient selection process. 
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The selection process was improved further by the use of fluorescence activated cell sorting and 
an alternative protocol for transformation using glass bead abrasion was developed although with very 
low transfection efficiency (Faktorová et al., 2020). 
More recently Yadavalli et al. developed a CRISPR/Cas9 system to genetically modify P. marinus. 
This system allows for greater selection in genetic modification (Yadavalli et al., 2021). 
The genomes of P. olseni and P. chesapeaki were sequenced in 2021. This allows for a greater 
understanding of the Perkinsus species which will allow for better genetic modification (Bogema et al., 
2021). 
Vaccine Development 
In 2003, extracellular proteins (ECPs) from P. marinus, grown in culture, were harvested from the 
media and then given to mice. The goal was to create antibodies against P. marinus; however, it was 
unsuccessful because the mice did not produce an adequate immune response (Earnhart & Kaattari, 
2003). The two possible mechanisms for a suppressed immune response are the presence of PF68, an 
immunomodulatory surface-active agent, or by constituents of P. marinus secreted products (Earnhart & 
Kaattari, 2003). While the experiment may have been a failure in some respects, it opened the door for 
new possibilities in the study of parasitic diseases.  
In 2014, wild-type P. marinus was given to humanized-mice expressing HLA-DR4 molecules and 
lacking expression of mouse MH-class II molecules. This was done so that the CD4 T cell responses in the 
mice were solely based on the human HLA-DR4 molecule. It was found that when the mice were fed P. 
marinus, an immune response against P. marinus was activated. However, there was no noticeable 
pathology found in the mice (Wijayalath et al., 2014). This exploratory research supports the potential use 
of P. marinus as an oral vaccine, although further research is needed before it can be approved as a vaccine 
for human consumption.  
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While malaria has been the subject of research for decades, developing a vaccine continues to be 
a goal for researchers today. An effective vaccine against Plasmodium eludes researchers due to its 
complex life cycle and massive antigenic variability, insufficient knowledge of the immune responses 
triggered by the parasite and the lack of adequate animal experimentation models (Garrido-Cardenas, 
González-Cerón, Manzano-Agugliaro, & Mesa-Valle, 2019). The life cycle of the malaria parasite 
Plasmodium falciparum involves two hosts. While the infected female Anopheles mosquito feeds on the 
blood of a human, the human host is inoculated with sporozoites. The sporozoites will then infect liver 
cells before maturing into schizonts, which will then rupture and release merozoites causing infection in 
the erythrocytes. After initial replication in the liver, the parasites will undergo asexual replication in 
erythrocytes. Once the parasite has entered the blood, it has entered into the clinical stage of malaria. 
Another Anopheles mosquito will come and feed on the infected human host. The parasite will then 
multiply inside the mosquito’s stomach before making its way to the salivary glands and perpetuating the 
cycle. To add to the complexity, Plasmodium is an obligate intracellular parasite, meaning that it cannot 
replicate outside its host (Stanisic, Barry, & Good, 2013).  
Targeting specific proteins of interest becomes challenging with Plasmodium parasites. Expressing 
proteins of interest in the in vitro model can be challenging even if successful. This can be overcome by 
over-expressing the specific protein in the in vitro model. However, the parasite would still need to be 
isolated from the host cell and then risk the contamination from host cell proteins. Yields of proteins can 
vary from 0.9 to 406.6 mg/L of media depending on the expression study (Mehlin et al., 2006). There’s 
also the problem of amino acid substitutions and the presence or absence of post-transcriptional 
modification systems. This can lead to the synthesis of inaccurate protein structures and/or functions 
(Schneider, King, & Marletta, 2005). An important transcriptional process is glycosylation of proteins. 
However, there is still much to learn on this process in the Apicomplexa (Rodrigues et al., 2015) and its 
significance. In other phylum, glycosylation has a significant effect on protein half-life and function; hence 
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it must be efficiently controlled. A system that produces the correct proteins is vital to inducing an immune 
response.   
One of the most popular systems to use to express apicomplexan proteins is the Escherichia coli 
expression system, partly because it is one the cheapest choices. The solubility problems of the 
recombinant product reflect that incorrect folding can lead to reduced antigenicity for vaccine 
applications. While there have been many advances to optimize protein production, including novel 
strains (Dutta, Ware, Barbosa, Ockenhouse, & Lanar, 2001), plasmids, and methodologies (Pandey et al., 
2002), the soluble recombinant apicomplexan proteins remain low in prokaryotic systems (Aguiar et al., 
2004; Mehlin et al., 2006; Vedadi et al., 2007).     
 Vaccine Delivery Systems 
 Vaccines have become a vital factor in reducing the prevalence of infectious diseases. The 
majority of vaccines are administered either by subcutaneous or intramuscular injection. The immune 
response is limited to systemic immunity (antibody production) against the pathogen or toxin with limited 
cellular immunity (T- and B-cell response) and weak protection generated at the mucosal surfaces (Vela 
Ramirez, Sharpe, & Peppas, 2017). When the activity of T and B-cells is induced, the adaptive immune 
system kicks into high gear. The lymphocytes will then differentiate into long-lived memory cells that will 
rapidly respond if the microbe is encountered in the future (Irvine, Swartz, & Szeto, 2013). Traditional 
vaccines used clinically contain either dead or live-attenuated microorganisms, inactivated toxins, protein 
subunits, and polysaccharide antigens or conjugates. Some issues with traditional forms of vaccines 
include pain and distress with injections and require highly trained personnel for administration. There is 
the possibility of needle-stick injuries or the reuse of contaminated needles. Also limited vaccine supply 
and/or production can prove problematic when a mass vaccination is necessary. Also, the conditions of 
storage of the vaccine can prove problematic. Most vaccines require a cold chain delivery system. 
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 One way to combat some of the issues with vaccines is to deliver them orally. Turning the vaccine 
into a pill, reduces many of the costs of traditional vaccines: a cold chain delivery system is no longer 
required, the risks of using needles goes away, and the need for highly trained personnel goes away. Also, 
if a vaccine requires boosters, a person is more likely to take it in pill form than go back for a subsequent 
shot. They can take the pills on their own time as opposed to scheduled appointments. People are happy 
to do this to treat as simple a condition as a headache, taking pills throughout the day or once a day over 
a period of time. Taking multiple doses of an oral vaccine should not deter the success of the approach. 
Also, comparing the efficiency of oral vaccines vs injection vaccines is not a fair comparison. They induce 
an immune response in different parts of the body via different pathways (New, 2019).  
Media Preparation and Replacements 
 One of the big challenges with parasitic growth is being able to grow the parasite without its host. 
Even though Perkinsus was discovered in 1950 (Mackin et al., 1950), a continuous  in vitro method to grow 
the organism was not established until 1993. Gauthier & Vasta developed three possible media 
formulations all with the addition of 5% oyster serum. The three media formulations were Dulbecco’s 
modified Eagles medium (DMEM) with 20% fetal bovine serum (FBS), DMEM:Ham’s F-12 (1:1) with 10% 
FBS, or DMEM: Ham’s F-12 (1:2) with 10mM Hepes/43 mM sodium bicarbonate or 100mM Hepes/7mM 
sodium bicarbonate. The minimal effective concentrations of antibiotics used to prevent contamination 
were 100 U/mL of penicillin G and streptomycin sulfate  (Gauthier & Vasta, 1993).  
 The media formulation was then further refined in 1995. Gauthier & Vasta determined the 
optimum temperature, salinity and pH rangers were 28-30°C, 25-30 ppt, and 6.6-6.8 respectively. The 
optimal growth media formation was determined to be DMEM: Ham’s F-12 (1:2) with the addition with 
5% FBS. Higher concentrations of FBS (10-20%) were determined to be inhibitory. Oyster serum was 
determined to only enhance growth at low concentrations of FBS (0-.1%)(Gauthier & Vasta, 1995).  
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 To investigate the inhibitory effect of high FBS concentrations, three major glycoproteins 
(transferrin, fetuin, and albumin) were tested in a serum free media to determine their effects on the 
proliferation of Perkinsus. At the concentrations tested in the study, fetuin enhanced the growth rate, 
albumin had a slight positive effect on the growth rate, and transferrin inhibited the growth rate 
(Gauthier, Feig, & Vasta, 1995). This media formulation became the gold standard for in vitro culturing of 
Perkinsus marinus.  
 Twenty-One years after in vitro culture was established, a new way for Perkinsus to be cultured 
was developed. In 2016, Cold, et al. developed an agar based plating method for Perkinsus marinus. 
However, they still used the media formulation developed in 1995. They just modified and optimized it to 
contain agar (Cold, Freyria, Martínez Martínez, & Fernández Robledo, 2016).  
 In the past 25 years, the media formulation for Perkinsus marinus has not changed significantly. 
What has changed significantly is the price of the media. The cost of ingredients is only going up. One 
reason the cost is increasing is because FBS must come from cattle herds grown in USDA approved 
countries. Every batch/lot must be traceable back to its country, slaughter house, and herd of origin. All 
lots must be tested for viral contamination, sterility, endotoxin levels, mycoplasma content and other 
constituents (Minonzio & Linetsky, 2014). In 2019, FBS costed $185 for 100 mL and on Nov 8th, 2020 Fisher-
Scientific listed FBS for $204 for 100 mL. Larger scale production reduces prices to an extent, however 
finding a suitable, cost effective replacement for FBS is challenging.  
 In 2018, a team of researchers were trying to determine the production of calcium-binding 
proteins in Crassostrea virginica in response to increased CO2 concentrations. While C. virginica is the host 
of Perkinsus, this paper did not seem to directly apply to host-parasite interactions. What was interesting, 
was that in order to grow C. virginica they didn’t use FBS to supplement the growth media. Instead, they 
used chicken serum (CS) (Richards, Xu, Mallozzi, Errera, & Supan, 2018). Because the host of Perkinsus 
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was able to be maintained by CS, this led to the possibility that it would be used as a replacement in the 
media formulation for Perkinsus. In terms of cost, on Nov 8th, 2020, Sigma-Aldrich listed chicken serum 
for $34.70 for 100 mL.  
 If FBS could be replaced with CS, this would be an 81% cost decrease for this one ingredient. With 
FBS in the media (using 2019 numbers), the whole media costs $123.98 per liter vs $48.67 per liter with 
CS in the media. Using CS, the overall cost would decrease by 60%.  
 
Modeling Bioprocess 
 Modeling a simulation can be an invaluable tool to engineers in learning and researching a 
process. There are a number of different software programs used in academic and industry settings. Two 
of the most commonly used programs are AspenPlus (Aspen Technology, Inc., Bedford, Massachusetts) 
and SuperPro Designer v10 (Intelligen, Inc., Scotch Plains, New Jersey). 
 AspenPlus is a chemical process simulator that was initially developed primarily for the oil and 
petrochemical industries, and is best suited to continuous steady state processes. Since its initial 
development, it has broadened its applications to a greater diversity of industries and can now include 
aqueous processing environments, however it is still best suited to its original applications. AspenPlus 
comes in a variety of packages to suit the needs of research and industry. Given a process design and 
thermodynamic models, AspenPlus uses mathematical models to predict the performance of the process. 
The information is then used in an iterative fashion to optimize the design. The accurate modeling of 
thermodynamic properties allows AspenPlus to handle very complex and non-ideal chemical systems 
including multiple-column separation systems, chemical reactors, and distillation of chemically reactive 
compounds. One of the draw backs to AspenPlus is that it does not assist in designing the process. The 
user must have a solid understanding of the chemical engineering principles and processes required to 
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input parameters and evaluate the results obtained.  This makes AspenTech more suitable for industrial 
chemicals and fuels, and for continuous processes.  
 SuperPro Designer v10 is another popular tool in research and industry. SuperPro Designer v10 is 
used to model, evaluate, and optimize batch or continuous processing as well as combinations of batch 
and continuous. Scheduling batch process operations is one of the key distinguishing features of SuperPro 
Designer v10, and this makes it particularly suitable for modeling fermentation processes, which due to 
their need for sterility are typically run-in batch mode. SuperPro Designer v10 has been used in variety of 
industries including: Biotech, Pharmaceutical, Specialty Chemical, Food Processing, Consumer Goods, 
Metallurgical, Materials, Water Purification, Wastewater Treatment, and Air Pollution Control. SuperPro 
Designer v10 allows manufacturing and environmental operation models in the same tool to allow users 
to optimize manufacturing while preventing pollution.  
 SuperPro Designer v10 has user friendly interface allowing for ease of use. Users create a flow 
diagram to model the process, declare the materials used in the process and initialize its operations. 
SuperPro Designer v10 has databanks that include physical and thermodynamic databanks for more than 
1200 materials and the option to add materials to the databanks. SuperPro Designer v10 includes: models 
for over 140 unit procedures, rigorous reactor modules, material and energy balances, chemical 
component and mixture database, equipment and resource databases, equipment sizing and cost, 
thorough process economics, scheduling of batch operations, throughput analysis and debottlenecking, 
resource (utilities, raw materials, and labor) tracking as a function of time, waste stream characterization, 
environmental impact assessment, and compatibility with a variety of graphics, spreadsheet, and word 
processing packages.  SuperPro Designer v10 can generate comprehensive reports that provide 
information on material and energy balances, equipment sizing, capital and operating cost estimation, 
throughput analysis, environmental impact assessment, and emissions of volatile organic compounds. 
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 The modeling software chosen for this project was SuperPro Designer v10, for many of the 























1) P. marinus was grown in DMEM: Ham’s F12 (1:2) 5% FBS as reported elsewhere (Gauthier & 
Vasta, 1995).  
All glassware needed for the experiment was autoclaved at 121°C for 1 hour. Glassware was then 
left under a UV light overnight to cool down before use the next day. All tubing used for sterilization was 
autoclaved at 121°C for 1 hour and then left under a UV light to cool down before use the next day.  
Once vessels are cool, media was prepared in volumes of 2 liters using the following method: first 
dissolve 30 grams of artificial sea water in 1.6 liters of sterile water. Next add 10 grams of DMEM and 20 
grams of Ham’s F12, dissolving both completely. Then, add 24 grams of HEPES buffer and 0.6 grams 
NaHCO3. Next add the antibiotics: Add 0.12 grams penicillin G and 0.26 grams streptomycin sulfate. If 
necessary, adjust the pH to 6.6 with NaOH or HCL. Next, add 100 milliliters of FBS. Finally, pass the media 
through a 0.2-micron sterilization filter. Media is stored in the refrigerator (≈4°C) until use.  
2) Media was also prepared by replacing 100 milliliters of FBS with 100 milliliters of chicken serum 
(5% v/v) 
3) For chicken serum optimization, DMEM: Ham’s F12(1:2) was prepared with chicken serum 







Perkinsus marinus PRA-240 Wild Type and PRA-393 GFP mutant cells were obtained from Dr. José 
A. Fernández Robledo and Dr. Raghavendra Yadavalli (Bigelow Laboratory for Ocean Sciences, East 
Boothbay, Maine) (Fernández-Robledo et al., 2008). 
P. marinus was grown in T-75 flasks and kept in an incubator at 26-28°C.  
First, warm media up to 28°C in a water bath. Next, in a biological safety hood, transfer 20 mL of 
media into T-75 flask using serological pipettor. Using serological pipettor, transfer 5 mL of media + cells 
into T-75 flask (cell density should be approximately 0.8 A). Place the T-Flask containing the cells in the 
incubator at 26-28°C and allow to grow until optical density is 0.8 A (approximately 8-10 days) 
Bioreactors 
The DAS-GIP system is a multicomponent system (Figure 4). The 4 vessels each have a volume of 
400 mL, with a working volume of 300mL (Figure 5).  




Vessels were autoclaved for 60 minutes at 121°C. Vessels are then left under UV light for 24 hours 
to allow the glass to cool down. Media is then transferred into the vessels under a sterile hood. Vessels 
are then hooked up to the DAS-GIP system.  
Variables to be controlled: pH, temperature 
Variables to be measured: pH, temperature, redox – DAS-GIP logs measurements approximately 
every 30 seconds. 
Aeration of the bioreactors was done by continuous purge of the head space instead of 
submerged sparging. When the sparger was immersed in the medium, the air caused the media to 
instantly start foaming. When bubbles start to form in the medium, it can lead to the wetting of exit vents 
and increasing the chance of bacterial contamination on a small scale. On a larger scale, we could have 
bacterial contamination and also lower cell growth. We were also concerned that an anti-foaming agent 
could have a negative impact on cell growth. The best option, at this small scale, was to aerate the system 
in the headspace. The surface area to volume ratio of the head space is 0.44 cm-1. The surface area to 
volume ratio of the whole reactor is 0.8 cm-1.  
Figure 5 Bioreactors A) Shows an Empty Bioreactor B) Shows A bioreactor at the end of a 
fermentation C) Shows an empty bioreactor in the housing 
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Vessels are inoculated with 15-20 mL of cells suspended in their medium with an optical density 
of 0.8. The system is allowed to run for 8-10 days. Cells are grown at 28°C, 200 rpm, aeriation of 
approximately 3.5-4 mL/s in the headspace, or 1.2-1.33 headspace vol/min. pH and Redox measurements 
are logged throughout the experiment by the DAS-GIP control system. 2 mL are taken out each day for 
analysis using a 3 mL syringe and a 22Gx4’’ needle.  
 Flasks 
5 mL of P. marinus were pipetted into 20mL of media in a T-75-Flask and allowed to grow 8-10 
days before re-culturing. 1 mL was taken out each day for analysis.  
Analysis 
P. marinus was spun down at 3.6 x G for 1 minute using a Sorvall Legend Micro 21 centrifuge. The 
media was siphoned off for HPLC analysis using a 1000 µL pipettor. The cells were then resuspended in 1 
mL of 0.5 M NaCl solution. The absorbance was taken using Genesys 10S UV-VIS Spectrophotometer at 
600 nm.  
Dry Weight 
 Method 1 
To determine dry weight of cells, first spin down 1 mL of P. marinus cells at 3.6 x G for 1 minute 
using a Sorvall Legend Micro 21 centrifuge. Then, remove the media from the microcentrifuge tube using 
a 1000 µL pipettor. Wash the cells with 1 mL of 0.5M NaCl solution to remove excess media. Next, take 
the absorbance of the cells at 600nm using a Genesys 10S UV-VIS Spectrophotometer. Record the 
absorbance. Then, spin down 1mL of p. marinus cells at 3.6 x G for 1 minute using a Sorvall Legend Micro 
21 centrifuge. Remove the sodium chloride solution from centrifuge tube leaving behind the cell pellet. 
Weigh the aluminum drying dish without cells and then transfer the cell pellet to an aluminum drying dish. 
18 
 
Wash centrifuge tube with 40 µL of 0.5M NaCl to get all the cells out of the tube and into the drying dish. 
(Mathematically, 40 µL of 0.5M NaCl weighs 0.0011688 grams. Subtract this number from the total at the 
end). Transfer the 40 µL to the aluminum drying dish and then place the aluminum drying dish in 100°C 
oven for 6-24 hours, until there is no decrease in weight. Place the drying dishes into a desiccator and 
allow them to cool completely. Weigh the dishes and record the weight and then subtract out the 40 µL 
of NaCl.  Put the dishes back in the oven for an hour, then weigh them again once cool to determine if 
there is any decrease in the weight.  
 Method 2 
First spin down 5 mL P. marinus cells in a 15 mL centrifuge tube at 360 x G for 5 minutes using an 
accuSpinTM 400 benchtop model. Decant the media from the centrifuge tube. Wash the cells with 1 mL DI 
water to remove excess media. Spin down the cells again. Remove the DI water from the centrifuge tube. 
Weigh the crucible and record the number. Transfer the cell pellet to a crucible. Wash the centrifuge tube 
with 40 µL of DI water and then transfer the 40 µL to the crucible. Place the crucible into a 100°C oven for 
6-24 hours, until there is no decrease in weight. Place the crucibles into a desiccator and let cool for 1 
hour. Weigh the crucibles and record the number. The crucibles are then ready for ashing.   
 
Ashing Cells 
First weigh the empty crucibles and record the number. Place the empty crucibles in the muffle 
furnace for 1 hour at 525°C. Using tongs, place the crucibles in a desiccator for 1 hour to cool down to 
room temperature. Weight the crucibles and record the weight. Add the dried cell sample to the dried 
crucibles and record the weight. Next, place the crucible holding the sample in the muffle furnace for 2 
hours at 525°C. Using tongs, place the crucibles into a desiccator for 1 hour to cool to room temperature. 
Weigh the crucible and record the weight. Place the crucible back into the muffle furnace for 1 hour at 
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525°C. Again, place crucible into a desiccator for 1 hour to cool to room temperature. Weigh the crucible 
and record the weight to be sure that it is constant (±0.3mg).  
 
High Performance Liquid Chromatography  
Each sample was filtered through a 0.45 nylon micron filter after the addition of 4-5 drops of 
H2SO4 to acidify the sample. Each sample ran for 35 minutes at 45°C using an AminexHPx87H column. The 
following parameters were used for each run: 1 replicate for each run, 15 µL of sample were injected for 
the run, the mobile phase used was 5 mM H2SO4, the flow rate for the column was 0.6 ml/minute, 5g/L 
glucose standards were used to calibrate system, the detection system is the RID-10A (refractive index 
detector), and the column temperature was 45°C.  
 
Super Pro 
The different flowsheet configurations were simulated using Super Pro Designer (Intelligen, Inc., 
Scotch Plains, New Jersey) due to its capability to model bioprocess and unit procedures bank. See Chapter 









CHAPTER 3  
EXPERIMENTAL RESULTS 
  
Table 1 summarizes the similarities and differences for each experiment detailing the number of 
vessels, cell types grown, which media was used, the air supply, HPLC data, absorbance data, and the 
purpose of each experiment.   
Table 1 Experimental Differences 
Experiment Number of 
Vessels 
Cell Type(s) Media 
Type(s) 
Air Supplied HPLC data Absorbance 
Data 
Purpose 
1 2 PRA-240 
WT 
FBS  No No Yes Demonstrate 
Growth in 
bioreactor 
2 2 PRA-240 
WT 
FBS  Yes No Yes Demonstrate  
Growth in 
bioreactor 
3 2 PRA-240 
WT 
FBS Yes Yes Yes Demonstrate 
Growth in 
bioreactor 
4 4 PRA-240 
WT 
FBS Yes No No Maximize 
growth 
5 4 PRA-240 
WT 
FBS & CS Yes No Yes Compare 
growth 
mediums 
6 4 PRA-240 
WT 
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Experiment 1: First Attempt to grow Perkinsus in Bioreactors 
The first experiment that was run with the bioreactors was a learning curve experiment. The 
absorbance, as displayed in Figure 6, shows that something was growing.  However, it is my belief that 
the something growing was not Perkinsus, but bacteria because the absorbance doubled faster in Vessel 
2 than in the small-scale experiments. Vessel 1 does not double as fast as vessel two, but I also believe 
that bacteria were growing in the vessel. Evidence for this is that once the cells were spun down, they 
should be a white-clear color. In this experiment, the cell pellet was tinted red. However, one can see in 
the redox, as displayed in Figure 7, is negative for the whole experiment indicating limited oxygen present. 
Lack of oxygen is likely, because the air was not turned on until the slight spike seen around time 25-4-19.  
 




Experiment 2: Second Attempt to Grow Perkinsus in Bioreactors 
This experiment we fixed the air supply, so both vessels had oxygen throughout the whole 
experiment. As in Experiment 1, this experiment used 2 vessels, FBS Medium and wild-type cells. As can 
be seen in Figure 8, the growth curve aligns more closely with the known doubling time (16-24hrs) of 
Perkinsus. A One-Way ANOVA on the two growth curves, yields a P-value of 0.017 indicating that the two 
growth curves are significantly different. This could be attributed to slightly different inoculum sizes, or 
possibly the vessels got contaminated with bacteria. There was no visible evidence of contamination, but 
the redox graph, Figure 9, shows limited oxygen present at the beginning of the experiment with negative 
numbers for the first few days. Oxygen doesn’t become saturated in the growth medium until after 
7/5/19. We then see another spike downwards in the redox after 7/9/19.  






Figure 8 Growth Curve PRA-240 WT cells in FBS media 
Figure 9 Redox Curve 
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Experiment 3: Third Attempt to Grow Perkinsus in Bioreactors 
This experiment the two vessels were grown in FBS medium. A One-way ANOVA done on the growth 
curves, as displayed in Figure 10, gives a P-value of 0.089 indicating no significant difference between the 
two curves.   
Under the microscope, the cell density increases by day 3 with the cells filling the field of view. 
The cells are uniform in size. Day 4 the cells look bigger under the microscope, and there is a higher 
number of larger cells while some cells remain smaller. By the end of the experiment, the cells have 
reduced in size. There are no detectable differences between the cells in the different vessels.   
As can be seen in Figure 11, the Redox curves for the two vessels match shape very closely. The 
negative spike at the beginning indicates the time when the cells were injected into the vessel. The rest 
of the experiment, the redox values stayed positive indicating that oxygen was present the entire time. 
This is the first experiment where the Redox graph has stayed positive for the whole experiment, and 
Figure 10 Growth Curve PRA-240 WT cells in FBS media 
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there were no visible signs of contamination. This leads to the idea that the redox curve could provide a 
real time indication of contamination.  
This is the first experiment where HPLC was run to determine glucose concentrations in the media 
over the course of the fermentation. Figure 12 shows how the concentration of glucose decreases in the 
media over time. Both vessels follow a similar trend in that glucose is consumed during the fermentation. 
It is interesting to note that the levels detected do not go to zero. On day zero, the glucose levels are 
approximately 3.1 g/L and only drop to approximately 2.8 g/L.  The difference between the start and end 
of the experiment is only 0.3 g/L. The glucose levels in media free from cells is slightly lower than media 
with cells because the inoculum has glucose present, slight raising the glucose levels. Figure 13 shows a 
zoomed in HPLC trace show detection of glucose.   

































































































































































Figure 13 HPLC Trace 
Figure 12 Glucose Concentration This graph shows how the glucose concentration was 
changing over the course of the fermentation 
27 
 
Experiment 4: Expanding from 2 Bioreactor Vessels to 4 Bioreactor Vessels  
 This experiment was expanded from 2 vessels into 4 vessels. Cells grown were wild-type in FBS 
Medium. The absorbance data were not recorded for this experiment partly because of the real time 
measurements of the redox, as displayed in Figure 14. Figure 14 indicates that negative values of vessels 
2, 3 and 4 are all contaminated with bacteria. However, the shape of Vessel 1 matches the shape of the 
redox graph from experiment 3, which was a clean culture experiment. This indicates that out the 4 
vessels, only vessel 1 was not contaminated and growing only Perkinsus. On Day 1, all the vessels appeared 
normal under the microscope. By Day 2, vessels 2, 3, and 4 had visible bacterial contamination while vessel 





Figure 14 Redox Curve 
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Experiment 5: Comparing PRA-240 WT Growth in FBS Media to Growth in CS Media 
 This experiment compares growing PRA-240 WT cells in either FBS or CS media. Vessels 1 and 3 
contain FBS media and vessels 2 and 4 contain CS media. The absorbance data at 600 nm is displayed in 
Figure 15.  
 
Table 2 Grouping Information for Figure 15 Using the Tukey Method and 95% Confidence 
Vessel N Mean Grouping 
2 12 0.991 A 
4 12 0.933 A 
1 12 0.6797 A 
3 4 0.627 A 
Means that do not share a letter are significantly different. 
Figure 15 Growth Curve PRA-240 WT cells in FBS and CS media 
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Absorbance data for vessel 3 was no longer recorded after day 4 because the jump in absorbance was 
too high to be growing only Perkinsus. The Redox graph, displayed in Figure 16, stays negative for the 
length of the experiment. The negative values, and lack of characteristic shape, indicated that vessel 3 
was contaminated with bacteria. The other three vessels showed no signs of contamination until the 
end of the experiment when vessels 4 and 2 dipped into negative Redox values. Vessel 1’s Redox stayed 
positive for the whole experiment and has the characteristic shape indicating that there was no 
contamination present. A One-Way ANOVA on the absorbance curve gives a P-value of 0.215 indicating 





Figure 16 Redox Curve 
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Experiment 6: Comparing PRA-240 WT Growth in FBS Media to Growth in CS Media  
This experiment compares PRA-240 WT cells grown in FBS or CS media and is a repeat of 
Experiment 5. Vessels 1 and 2 contain FBS media and vessels 3 and 4 contain CS media. Figure 17 displays 
the absorbance data over time for this experiment. A One-Way ANOVA done over the graph gives a P-
value of 0.835 indicating no statistical difference in the growth of Perkinsus with either FBS or CS media.  
 
 
Table 3 Grouping Information for Figure 17 Using the Tukey Method and 95% Confidence 
Factor N Mean Grouping 
Vessel 3 16 0.6889 A 
Vessel 4 16 0.6390 A 
Vessel 2 16 0.6156 A 
Vessel 1 16 0.6026 A 
Means that do not share a letter are significantly different. 
 
Figure 17 Growth Curve PRA-240 WT cells in FBS and CS media 
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In addition, there were no noticeable differences when looking under the microscope at the cells between 
the vessels. As displayed in Figure 18, The Redox values stay positive and are only negative when the cells 
were injected into the vessels. All 4 curves show the characteristic shape to indicate that only Perkinsus is 
growing in the bioreactors.  
 Figure 19 shows how the average glucose concentration decreases over time. For the FBS vessels, 
vessel 1 starts at 2.1 g/L and ends at 1.6 g/L. Vessel 3 starts at 1.9 g/L and ends at 1.6 g/L. For the CS 
vessels, vessel 2 seems to not be very steady over time. There could have been issues with samples as 
they went through the HPLC. Vessel 4 starts at 1.95 g/L and ends with 1.5 g/L. 

















Figure 20 HPLC Trace 
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Chicken Serum Optimization 
 This experiment was done using PRA-240 WT cells at small scale in 75 mL T-flasks in triplicate for 
each level of CS. The CS levels tested in the flasks were: 0, 0.1, 1, 5,10, 20% v/v CS.  
 On Day 1 under the microscope, in the serum free flasks, the cells appeared more stationary and 
not as suspended in the medium as normal. 0.1 and 1% CS flasks had more growth compared to serum 
free. 5, 10 and 20% CS flasks all had normal growth. On Day 2, it did not appear as if there was any growth 
happening in the serum free flasks. The rest of the concentrations appeared to have cells growing and 
happy. On Day 3, the serum free cells finally started to grow and there are no noticeable differences 
between the flasks. On Day 4, the cells in serum free flasks seemed to be clumping together more so than 
normal while the rest of the concentrations appear to be normal. By Day 9, all the cells appeared to be 

























Average Absorbance Over TIme
Average Serum Free Average 0.1% CS Average 1% CS
Average 5% CS Average 10% CS Average 20% CS
Figure 21 Growth Curve 
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Table 4 Grouping Information for Figure 21 Using the Tukey Method and 95% Confidence 
Factor N Mean Grouping 
    
20 27 0.8510 A   
10 27 0.7523 A B 
5 27 0.6557 A B 
1 27 0.5414   B 
0.1 27 0.5371   B 
SF 27 0.5030   B 
Means that do not share a letter are significantly different. 
Figure 21 gives the absorbance data for each concentration over time. A One-Way ANOVA done 
over the curves gives a P-value of 0.00058 indicating a statistical difference between the different 
concentrations. Table 4 gives the more detailed Tukey method for grouping the curves together.  
Statistically speaking, there is not a difference between 5, 10 and 20%. 5% CS is the minimum 
concentration needed for abundant growth. While there was growth at the lower levels of concentration, 
there’s enough of a difference that it’s not worth using less than 5% CS in the media.   
Figure 22 shows how the glucose concentration changes for the different concentrations of 
chicken serum media and how the glucose concentration changes over time. The serum free curve shows 
very little change in the concentration of glucose. This supports the slower growth curve in Figure 21. The 
cells ate less and were lacking nutrients necessary to achieve full growth. For the rest of the curves, the 
glucose concentration decreases over time. Although the glucose concentration does not approach zero. 
This suggests that glucose is not the limiting nutrient in the media for optimized growth. The limiting 
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nutrient is likely a molecule in chicken serum because growth increases as the percentage of chicken 
serum increases.  
 
Experiment 7: Comparing Cell Types in FBS Media  
 This experiment was to switch gears from media and try to grow genetically modified organisms 
in the bioreactor compared to wild type organisms. Vessels 1 and 3 contain PRA-240 WT cells in FBS media 
and vessels 2 and 4 contain PRA-393 GFP cells in FBS media. PRA-393 GFP cells have an inserted plasmid 
attached to PmMOE gene with a GFP tag for expression (Fernández-Robledo et al., 2008).  
Figure 22 Glucose Concentration 
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Figure 23 displays the absorbance data at 600nm for each vessel. All four redox graphs, in Figure 24, 
display the characteristic shape of a run free of contamination. Vessel 2 has a few areas where the redox 
dipped negative, however when looking at the cells under the microscope there were no visible signs of 
contamination. When comparing all the vessels under the microscope, there were no noticeable 
differences between all four bioreactors.    
  
Table 5 Grouping Information for Figure 23 Using Tukey Method and 95% Confidence 
Vessel N Mean Grouping 
1 18 0.5741 A   
2 18 0.5187 A   
4 18 0.3892 A B 
3 18 0.2964   B 
Means that do not share a letter are significantly different. 





This experiment confirmed that the rate of aeration is important to the growth of Perkinsus. Vessel 3 had 
a clogged air filter, which did not allow proper ventilation for the first 4 days of the experiment. On day 4, 
the air filter was replaced and the growth normalized to an extent.  A One-Way ANOVA over the 
absorbance curves gives a P-Value of 0.004. Table 5 gives the breakdown of how the curves are statistically 








Figure 24 Redox Curve 
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Experiment 8: Comparing PRA-393 GFP Growth in FBS Media with Growth in CS Media 
This experiment compares PRA-393 GFP cells with FBS media and CS media. Vessels 1 and 3 
contain FBS media. Vessels 2 and 4 contain CS media. Under the microscope, there are no noticeable 
differences between cells from Day 1 to Day 3. On Day 3, all the cells appear to be in the growth phase. 
On day 4, Vessel 2 had visible bacterial contamination. The bacteria appeared to be taking over the 
culture. On Day 7, the University of Maine had a power failure in Jenness Hall. The computer running the 
bioreactors shut down and the system stopped recording pH, the temperature and the redox. When the 
power came back on, the system seemed to still be holding at the correct temperature, and the 
experiment ran for one more day without recording the temperature, pH and the redox. On Day 8, there 
were no visible signs of stress in the cells in vessels 1, 3 and 4. In Vessel 2, Perkinsus appears to have 
started growing again, taking the culture back from the bacteria. However, the culture is still visibly 
infected.  
 The absorbance data at 600 nm is given in Figure 25. A One-Way ANOVA done over the whole 
curve gives a P-value of 0.093 indicating that there isn’t a statistical difference in the growth rate. 
However, if you isolate the part of the curve after the contamination happened, a One-Way ANOVA gives 
a P-value of 0.000000003 and the grouping information is listed in Table 7. The growth in Vessel 2 is 
statistically different from the other vessels.  
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Table 6 Grouping Information for the whole curve for Figure 25 Using the Tukey Method and 95% 
Confidence 
Vessel N Mean Grouping 
2 16 0.739 A 
4 16 0.5104 A 
1 16 0.4857 A 
3 16 0.4657 A 
Means that do not share a letter are significantly different. 
Table 7 Grouping Information Day 4 and after for Figure 25 Using the Tukey Method and 95% Confidence 
Vessel_ N Mean Grouping 
2 8 1.2183 A   
1 8 0.7190   B 
4 8 0.6996   B 
3 8 0.6298   B 
Means that do not share a letter are significantly different. 
 
Figure 25 Growth Curve PRA-393 GFP cells grown in FBS and CS media 
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Figure 26 gives the Redox graph for Experiment 8. Vessels 1, 3 and 4 are all starting to display the 
characteristic shape for the growth of Perkinsus. Vessel 2 starts to display the shape, but between day 3 
and day 4 starts to go negative indicating the contamination.  
 
 Figure 27 shows how the glucose concentration changes over time. Vessels 1, 3, and 4 follow the 
same trend as previous experiments. The curves start around 2 g/L and drop to around 1.5 g/L. Vessel 2 
starts at approximately 2 g/L but then drops, over time, to almost zero. Vessel 2 was contaminated with 
bacteria, While Perkinsus eats the glucose slowly, bacteria eat consume glucose at a much faster rate. This 
is another indication that Vessel 2 was contaminated.  
 
 



















 The four different flow sheet configurations were simulated with SuperPro Designer. While the 
pure components database is extensive, five new compounds had to be added to create this model (FBS 
Media, CS Media, coating, stabilizers, and flavoring). For ease of modeling, all five of the compounds were 
thermodynamically based on water.  
Model 1 
 Figure 28 shows the model of what was done experimentally in the lab. In the stream labeled 
Media1, 20 mL of media (FBS media or CS media) enter into P-1/TRF-101 with the composition of: 4.0758% 
FBS or CS media and 95.9242% water. In the stream labeled Media/Biomass, 5 mL enter into P-1/TRF-101 
with the composition of 0.5% biomass, 4.5% FBS or CS Media, and 95% water.  P-1/TRF-101 is then allowed 
to ferment for 8 days before the entire contents of the flask are transferred to P-2/BR-101. In the stream 
labeled Media, 200 mL of media (FBS or CS media) are transferred into P-2/BR-101 with the same 
composition as the stream of Media1. P-2/BR-101 is then allowed to ferment for 8 days before 
Figure 28 Experimental Small-Scale Model 
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transferring the contents out of the bioreactor. The conversion factor is set to 99% for both P-1/TRF-101 
and P-2/BR-101 and the reaction is listed in Equation 1.  
0.83𝑀 𝐹𝐵𝑆(𝑜𝑟 𝐶𝑆)𝑀𝑒𝑑𝑖𝑎 + 1𝑀 𝑂2 + 1𝑀 𝑁2 →




Figure 29 shows a theoretical process of going from small scale growth to large scale (industrial) 
growth. The first step, is to make media (FBS or CS) in P-2/V-101. Once the media is well mixed, 20 mL 
pass through a sterilization filter, P-3/DE-101 before entering P-1/TRF-101. Using stream S-106, 5 mL of 
media and biomass with the composition of 1% biomass, 4% FBS or CS media, and 95% water enter into 
P-1/TRF-101. P-1/TRF-101 is then allowed to ferment for 8 days with a conversion factor set to 99% using 
the reaction listed in Equation 1. Using stream S-107, the media and biomass are transferred into P-4/DBS-
101. 
P-6/V-103 mixes 200 mL of media (FBS or CS) with a composition of 4.0758% FBS or CS media and 
95.9242% water and then passes the media through a sterilization filter, P-7-102, before entering P-
4/DBS-101. P-4/DBS-101 then ferments for 8 days with a conversion factor set to 99% using the reaction 
listed in Equation 1. P-5/AF-101 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-114, the entire contents of P-4/DBS-101 is transferred to P-8/DBS-102. 
 P-9/V-103 mixes 4 L of (FBS or CS) with a composition of 4.0758% FBS or CS media and 95.9242% 
water and then passes the media through a sterilization filter, P-10/DE-103 before entering P-8/DBS-102. 
P-8/DBS-102 then ferments for 8 days with a conversion factor set to 99% using the reaction listed in 
Equation 1. P-11/AF-102 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-123, the entire contents of P-8/DBS-102 is transferred to P-13/DBS-103. 
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 P-12/V-104 mixes 80 L of (FBS or CS) with a composition of 4.0758% FBS or CS media and 
95.9242% water and then passes the media through a sterilization filter, P-15/DE-104 before entering P-
13/DBS-103. P-8/DBS-102 then ferments for 8 days with a conversion factor set to 99% using the reaction 
listed in Equation 1. P-14/AF-103 is an air filter which reduces the chances of bacterial contamination 
during fermentation. Using stream S-128, the entire contents of P-13/DBS-103 is transferred to P-16/DBS-
104. 
P-18/V-105 mixes 1600 L of (FBS or CS) with a composition of 4.0758% FBS or CS media and 
95.9242% water and then passes the media through a sterilization filter, P-19/DE-105 before entering P-
16/DBS-104. P-16/DBS-104 then ferments for 8 days with a conversion factor set to 99% using the reaction 
listed in Equation 1. P-17/AF-104 is an air filter which reduces the chances of bacterial contamination 
during fermentation. Using stream S-132, the entire contents of P-16/DBS-104 is transferred to P-21/DC-
101 for centrifugation. 
P-21/DC-101 separates the biomass from the media. The media leaves via stream S-139 and is 
then heat sterilized in P-22/ST-101, before being disposed properly. The biomass exits via stream S-138 
to be freeze dried in P-20/FDR-101 with an initial loss on drying (LOD) of 4.57% and a final LOD of 0.01%.                                                                                                                                                                                                                                                                                                                                                                                                                                   
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Figure 29 Industrial Scale Up Model 
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 Model 3 
Figure 30 shows a theoretical process of going from small scale growth to large scale (industrial) 
growth with the added factor of turning the biomass into tablets for human consumption. The first step, 
is to make media (FBS or CS) in P-2/V-101. Once the media is well mixed, 20 mL pass through a sterilization 
filter, P-3/DE-101 before entering P-1/TRF-101. Using stream S-106, 5 mL of media and biomass with the 
composition of 1% biomass, 4% FBS or CS media, and 95% water enter into P-1/TRF-101. P-1/TRF-101 is 
then allowed to ferment for 8 days with a conversion factor set to 99% using the reaction listed in Equation 
1. Using stream S-107, the media and biomass are transferred into P-4/DBS-101. 
P-6/V-103 mixes 200 mL of media (FBS or CS) with a composition of 4.0758% FBS or CS media and 
95.9242% water and then passes the media through a sterilization filter, P-7-102, before entering P-
4/DBS-101. P-4/DBS-101 then ferments for 8 days with a conversion factor set to 99% using the reaction 
listed in Equation 1. P-5/AF-101 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-114, the entire contents of P-4/DBS-101 is transferred to P-8/DBS-102. 
 P-9/V-103 mixes 4 L of (FBS or CS) with a composition of 4.0758% FBS or CS media and 95.9242% 
water and then passes the media through a sterilization filter, P-10/DE-103 before entering P-8/DBS-102. 
P-8/DBS-102 then ferments for 8 days with a conversion factor set to 99% using the reaction listed in 
Equation 1. P-11/AF-102 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-123, the entire contents of P-8/DBS-102 is transferred to P-13/DBS-103. 
 P-12/V-104 mixes 80 L of (FBS or CS) with a composition of 4.0758% FBS or CS media and 
95.9242% water and then passes the media through a sterilization filter, P-15/DE-104 before entering P-
13/DBS-103. P-8/DBS-102 then ferments for 8 days with a conversion factor set to 99% using the reaction 
listed in Equation 1. P-14/AF-103 is an air filter which reduces the chances of bacterial contamination 
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during fermentation. Using stream S-128, the entire contents of P-13/DBS-103 is transferred to P-16/DBS-
104. 
P-18/V-105 mixes 1600 L of (FBS or CS) with a composition of 4.0758% FBS or CS media and 
95.9242% water and then passes the media through a sterilization filter, P-19/DE-105 before entering P-
16/DBS-104. P-16/DBS-104 then ferments for 8 days with a conversion factor set to 99% using the reaction 
listed in Equation 1. P-17/AF-104 is an air filter which reduces the chances of bacterial contamination 
during fermentation. Using stream S-132, the entire contents of P-16/DBS-104 is transferred to P-21/DC-
101 for centrifugation. 
P-21/DC-101 separates the biomass from the media. The media leaves via stream S-139 and is 
then heat sterilized in P-30/ST-101, before being disposed properly. The biomass exits via stream S-138 
to be freeze dried in P-20/FDR-101 with an initial LOD of 4.57% and a final LOD of 0.01%.   
After being freeze dried, the biomass enters P-22/NM-101 for nano-milling. The biomass then 
enters P-23/V-106 for the addition of stabilizers, flavoring, and water. After being mixed together, the 
mixture then is sent for granulation in P-24/GRN-101 until the final LOD is 5%. After granulation, the 
mixture is sent to a storage contain, P-25/V-107. From the storage container, the granulated mixture is 
sent to P-26/TP-101 to be turned into 1-gram tablets. The tablets are then sent to a storage container, P-




Figure 30 Industrial Scale and Creating Tablets Model 
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 From P-27/DB-101, the tablets then enter P-28/TB-101 to receive the coating around the tablet. 
P-28/TB-101 goes through 4 cycles of adding the coating to the tablets. The coating solution is pulled from 
P-29/V-108 into P-28/TB-10. 
 Model 4 
 After spending time looking at Model 3, there are some drawbacks to the way the process was 
modeled. For instance, in an industrial setting the media would not be made before each step as it was in 
Model 3. Model 4 seeks to solve this problem by making media in one bigger batch and then sending the 
media to each bioreactor as needed, which is displayed in Figure 31.  
 P-3/V-101 mixes together 2000 L of media with the mass composition of 4.0758% FBS or CS media 
and 95.9242% water. The media is then passed through a sterilization filter, P-5/DE-101 before entering 
P-4/V-102 for storage. This step cycles independently of the main recipe so that the media can be made 
without reference to whether or not cells are being grown.  
P-1/TRF-101 transfers in 20 mL of media from P-4/V-102 and then 5 mL of biomass and media 
with the mass composition of 0.5% biomass, 4.5% media, and 95% water. P-1/TRF-101 is then allowed to 
ferment for 8 days with a conversion factor set to 99% using the reaction listed in Equation 1. Using stream 
S-104, the media and biomass are transferred into P-2/DBS-101. 
P-2/DBS-101 transfers in 200 mL of media from P-4/V-102 and then the contents of stream S-104. 
P-2/DBS-101 then ferments for 8 days with a conversion factor set to 99% using the reaction listed in 
Equation 1. P-12/AF-101 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-108, the entire contents of P-2/DBS-101 is transferred to P-6/DBS-102. 
P-6/DBS-102 transfers in 4L of media from P-4/V-102 and then the contents of stream S-108. P-
6/DBS-102 then ferments for 8 days with a conversion factor set to 99% using the reaction listed in 
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Equation 1. P-13/AF-102 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-116, the entire contents of P-6/DBS-102 is transferred to P-8/DBS-104. 
P-8/DBS-104 transfers in 80L of media from P-4/V-102 and then the contents of stream S-116. P-
8/DBS-104 then ferments for 8 days with a conversion factor set to 99% using the reaction listed in 
Equation 1. P-14/AF-103 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-124, the entire contents of P-8/DBS-104 is transferred to P-7/DBS-103. 
P-7/DBS-103 transfers in 1600L of media from P-4/V-102 and then the contents of stream S-124. 
P-7/DBS-103 then ferments for 8 days with a conversion factor set to 99% using the reaction listed in 
Equation 1. P-15/AF-104 is an air filter which reduces the chances of bacterial contamination during 
fermentation. Using stream S-125, the entire contents of P-7/DBS-103 is transferred to P-9/DS-101 for 
centrifugation. 
P-9/DS-101 separates the biomass from the media. The media leaves via stream S-139 and is then 
heat sterilized in P-16/ST-101, before being disposed properly. The biomass exits via stream S-126 to be 
freeze dried in P-10/FDR-101 with an initial LOD of 4.57% and a final LOD of 0.01%.   
After being freeze dried, the biomass enters P-11/NM-101 for nano-milling. The biomass then 
enters P-23/V-106 for the addition of stabilizers, flavoring, and water. After being mixed together, the 
mixture then is sent for granulation in P-24/GRN-101 until the final LOD is 5%. After granulation, the 
mixture is sent to a storage contain, P-25/V-107. From the storage container, the granulated mixture is 
sent to P-26/TP-101 to be turned into 1-gram tablets. The tablets are then sent to a storage container, P-
27/DB-101. 
From P-27/DB-101, the tablets then enter P-28/TB-101 to receive the coating around the tablet. P-
28/TB-101 goes through 4 cycles of adding the coating to the tablets. The coating solution is pulled from 




Figure 31 Realistic Industrial Scale Model 
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Figure 31 Continued  
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Economic Analysis  
Calculations 
Across all the process models, the goal was to compare different scenarios and to determine 
which would be the most cost-effective-process. The different sensitivity variables included: Media Type 
(FBS vs CS), Bioreactor types (all disposable, all reusable and sterilizable, and 50/50 split with the first two 
being reusable and the second two being disposable), and different failure rates (10%, 25%, 50%) of the 
product.  
The economic analysis embedded in SuperPro Designer employs a capital budgeting approach to 
developing an estimate for overall capital and operating costs. The basis of the capital cost is the purchase 
cost of all the major equipment needed to fully equip a manufacturing plant. SuperPro deploys a database 
that contains major equipment purchase costs and then applies multiplier factors to include associated 
minor equipment and other capital costs. Operating costs are determined from consumable materials and 
supplies, labor estimates, utilities, wastes and disposals, and other associated fixed operating costs. The 
structure of these estimates is outlined below. 
 
𝐶𝑎𝑝𝑖𝑡𝑎𝑙 𝐶𝑜𝑠𝑡 = 𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑖𝑥𝑒𝑑 𝐶𝑎𝑝𝑖𝑡𝑎𝑙 (𝐷𝐹𝐶) + 𝑊𝑜𝑟𝑘𝑖𝑛𝑔 𝐶𝑎𝑝𝑖𝑡𝑎𝑙 (𝑊𝐶) + 𝑆𝑡𝑎𝑟𝑡 𝑢𝑝 𝐶𝑜𝑠𝑡𝑠 (2) 
 
𝐷𝐹𝐶 = 𝐷𝑖𝑟𝑒𝑐𝑡 𝐶𝑜𝑠𝑡 (𝐷𝐶) + 𝐼𝑛𝑑𝑖𝑟𝑒𝑐𝑡 𝐶𝑜𝑠𝑡𝑠 (𝐼𝐶) + 𝑂𝑡ℎ𝑒𝑟 𝐶𝑜𝑠𝑡𝑠 (𝑂𝐶) (3) 
 
𝐷𝐶 = 𝐸𝑞𝑢𝑖𝑝𝑚𝑒𝑛𝑡 𝐶𝑜𝑠𝑡(𝑃𝐶) + 𝑖𝑛𝑠𝑡𝑎𝑙𝑎𝑡𝑖𝑜𝑛 + 𝐴 + 𝐵 + 𝐶 + 𝐷 + 𝐸 + 𝐹 + 𝐺 (4) 
In which,  
𝑃𝐶 = 𝐿𝑖𝑠𝑡𝑒𝑑 𝐸𝑞𝑢𝑖𝑝𝑚𝑒𝑛𝑡 𝑃𝑢𝑟𝑐ℎ𝑎𝑠𝑒 𝐶𝑜𝑠𝑡 (𝐿𝐸𝑃) + 𝑈𝑛𝑙𝑖𝑠𝑡𝑒𝑑 𝐸𝑞𝑢𝑖𝑝𝑚𝑒𝑛𝑡 𝑃𝑢𝑟𝑐ℎ𝑎𝑠𝑒 𝐶𝑜𝑠𝑡 (𝑈𝐿𝐸𝑃𝐶)(5) 





= 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙𝑠 + 𝑐𝑜𝑛𝑠𝑢𝑚𝑎𝑏𝑙𝑒𝑠 + 𝑙𝑎𝑏𝑜𝑟 𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 + 𝑢𝑡𝑙𝑖𝑡𝑖𝑒𝑠 + 𝑤𝑎𝑠𝑡𝑒 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 + 
𝑓𝑎𝑐𝑖𝑙𝑖𝑡𝑦 𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 + 𝑙𝑎𝑏𝑜𝑟𝑎𝑡𝑜𝑟𝑦/ 𝑄𝐶/𝑄𝐴 + 𝑡𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡𝑖𝑜𝑛 + 𝑚𝑖𝑠𝑐𝑒𝑙𝑙𝑎𝑛𝑒𝑜𝑢𝑠 +
𝑎𝑑𝑣𝑒𝑟𝑡𝑖𝑠𝑖𝑛𝑔
𝑠𝑒𝑙𝑙𝑖𝑛𝑔⁄ + 𝑟𝑢𝑛𝑛𝑖𝑛𝑔 𝑟𝑜𝑦𝑎𝑙𝑡𝑖𝑒𝑠 + 𝑓𝑎𝑖𝑙𝑒𝑑 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑑𝑖𝑠𝑝𝑜𝑠𝑎𝑙 𝑐𝑜𝑠𝑡𝑠 (6)
 
 
𝑈𝑛𝑖𝑡 𝑃𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛 𝐶𝑜𝑠𝑡 =
𝑂𝑝𝑒𝑟𝑎𝑡𝑖𝑛𝑔 𝐶𝑜𝑠𝑡 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟











Table 8 Cost Calculations 
Direct Cost (DC)  
Piping(A) 0.35xPC 
Instrumentation(B) .40xPC 
Insulation [C] 0.03xPC 
Electrical Facilities [D] 0.1xPC 
Buildings [E] 0.45xPC 
Yard Improvement (F) 0.15xPC 
Auxiliary Facilities (G) 0.4xPC 
  




Other Cost (OC)  
Contractor's fee 0.5 x(DC+IC) 








Listed Equipment Purchase Costs 
 The purchase cost of the major equipment is based on the operating units in the process design, 
their size, operating conditions and the built-in cost model in Super Pro.   
 
Model 1 
Model 1 was used as a starting point to gain familiarity with the simulation software and develop 
a basis from which to build the rest of the models. An economic analysis was not done on Model 1 because 
it was not an industrial scale model.   
 
Model 2 
 Figure 32 shows the total cost for the major equipment in Model 2. The failure rate and media 
type do not play into major equipment costs. The only factor that plays into the major equipment costs is 
the bioreactor type. Reusable/sterilizable bioreactors cost a total of $4.3 million; systems that host 
disposable bioreactors cost a total of $3.9 million; 50/50 split cost a total of $3.6 million. A further 










   
Common Equipment   
Blending Tank (0.02L - 90L) 147,000 4 
Dead-End Filter 41,000 5 
Air Filter 7,000 4 
Blending Tank (1777L) 208,000 1 
Decanter Centrifuge 262,000 1 
Freeze Dryer 102,000 1 
Heat Sterilizer 190,000 1 
   
Disposable Scenario   
Disposable Bioreactor V= 
700L 221,000 7 
   
50/50 Split   
Bioreactor V = 0.34L 106,000 1 
Bioreactor V = 6.44L 106,000 1 
Figure 32 Major Equipment for Model 2 
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Table 9 Continued  
Disposable Bioreactor V= 
700L 221,000 5 
   
Reusable   
Bioreactor V = 0.34L 106,000 1 
Bioreactor V = 6.44L 106,000 1 
Bioreactor V = 128.46L 464,000 1 
Bioreactor V = 2568.83L 1,260,000 1 
 
Model 3 
 Figure 33 shows the total cost for the major equipment in Model 2. The failure rate and media 
type do not play into major equipment costs. The only factor that plays into the major equipment costs is 
the bioreactor type. Reusable/sterilizable bioreactors cost a total of $6.2 million; disposable bioreactors 
cost a total of $5.8 million; 50/50 split cost a total of $5.5 million. A further breakdown of equipment for 
Figure 33 Equipment Costs for Model 3 
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this model is listed in Table 3. These numbers go up compared to Model 2 because Model 3 includes the 
downstream process of making tablets out of the biomass, which includes more equipment. 
 






     
Common Equipment     
Blending Tank (0.02L - 90L) 147,000 5 
Dead-End Filter 41,000 5 
Air Filter  7,000 4 
Blending Tank (1777L) 208,000 1 
Decanter Centrifuge 262,000 1 
Freeze Dryer 102,000 1 
Heat Sterilizer 190,000 1 
Nano Mill 241,000 1 
Granulator 306,000 1 
Receiver Tank 51,000 1 
Tablet Press 225,000 1 
Discrete Bin 54,000 1 
Tablet Coater 345,000 1 
     
Disposable     
Disposable Bioreactor V= 
700L 221,000 7 
     
50/50 Split     
Bioreactor V = 0.34L 106,000 1 
Bioreactor V = 6.44L 106,000 1 
Disposable Bioreactor V= 
700L 221,000 5 
     
Reusable     
Bioreactor V = 0.34L 106,000 1 
Bioreactor V = 6.44L 106,000 1 
Bioreactor V = 128.46L 464,000 1 






 Figure 34 shows the total cost for the major equipment in Model 2. The failure rate and media 
type do not play into major equipment costs. The only factor that plays into the major equipment costs is 
the bioreactor type. Reusable/sterilizable bioreactors cost a total of $5.7 million; disposable bioreactors 
cost a total of $5.2 million; 50/50 split cost a total of $4.9 million. A further breakdown of equipment for 
this model is listed in Table 11. These numbers go down because unnecessary equipment (blending tanks 







Figure 34 Equipment Costs for Model 4 
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Common Equipment     
Flat Bottom Tank V = 6883.08 31,000 2 
Blending Tank V = 2224.76L 215,000 1 
Dead End Filter 41,000 1 
Disk Stack Centrifuge 219,000 1 
Freeze Dryer 102,000 1 
Blending Tank V = 35.93L 147,000 2 
Granulator 306,000 1 
Nano Mill 241,000 1 
Receiver Tank 51,000 1 
Tablet Press 225,000 1 
Discrete Bin 54,000 1 
Tablet Coater 345,000 1 
Air Filter 7,000 4 
Heat Sterilizer 190,000 1 
     
Disposable     
Disposable Bioreactor V= 
700L 221,000 7 
     
50/50 Split     
Disposable Bioreactor V= 
700L 221,000 5 
Bioreactor V = 0.34L 106,000 1  
Bioreactor V = 6.44L 106,000 1  
     
Reusable     
Bioreactor V = 0.34L 106,000 1 
Bioreactor V = 6.44L 106,000 1 
Bioreactor V = 128.46L 464,000 1 








Direct Fixed Capital  
 The Direct Fixed Capital (DFC) refers to the fixed assets of an investment, such as plant and 
equipment. There are direct and indirect costs associated with the DFC. How this number is calculated is 
shown in Equations 2 & 3 and Table 8.  
Models 2, 3, 4  
The DFC is not dependent on media type or the failure rate which can be seen in Figure 35. (Figure 
35 displays data from Model 4. Figures for the other models can be found in Appendix B). Neither number 
contributes to how the DFC is calculated. The lowest DFC for Model 2 is $24.06 million for the 50/50 split 
bioreactor scenario, which correlates to the lowest scenario for Capital Cost. The DFC does increase from 
Model 2 because there is more equipment needed in this model. With more equipment, a bigger plant 
would also be necessary. The lowest DFC for Model 3 is $37.2 million for the 50/50 bioreactor split. The 
Figure 35 Direct Fixed Capital for Model 4 
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lowest DFC for Model 4 is 50/50 bioreactors with $33.7 million.  This number is lower than Model 3 
because this model eliminates unnecessary equipment while still keeping the output as high as possible. 
Capital Cost 
The Total Capital Investment or Capital Costs refers to the fixed costs that are associated with a 
process. This is based on the Major Equipment Costs and is calculated as the sum of the following cost 
items over all sections of a process. Equation 2 shows how this number is calculated.  
Models 2, 3 and 4 
The next factor looked at was the Capital Cost of the models and how they changed with the 
different variables (media type, bio reactor type and failure rate).  All three models showed the same 
trends. They type of media (FBS or CS) had a slight effect on the Capital Cost with CS media being slightly 
lower than the cost with FBS media. The biggest effect on Capital Cost was the bioreactor types. Figure 36 
Figure 36 Capital Cost for Model 4 
63 
 
shows how the capital cost changes for Model 4. Figures for Models 2 and 3 can be found in Appendix B. 
Table 12 lists the capital costs for each model.  The Capital Costs increase from lowest $26.3 million in 
Model 2 to $39.7million in Model 3 because there are more process steps which requires more 
equipment. Model 4 decreases the Capital Cost to $35.9 million.  




Type Capital Cost (in millions) 
Model 2     
50/50 FBS $26.4 
  CS $26.3 
Reusable FBS $33.2 
  CS $33.1 
Disposable FBS $28.6 
  CS $28.6 
Model 3     
50/50 FBS $39.7 
  CS $39.7 
Reusable FBS $46.6 
  CS $46.6 
Disposable FBS $42.0 
  CS $42.0 
Model 4     
50/50 FBS $36.0 
  CS $35.9 
Reusable FBS $43.4 
  CS $43.3 
Disposable FBS $38.8 
  CS $38.7 
 
 
 Capital Cost per kg or Tablet 
 Another way to look at the capital cost is to look at the how the capital cost changes per kg of 
biomass produced or tablet. Equation 8 shows how this number is calculated. All three models produce 
36 batches per year with a project lifetime of 15 years. With zero product failure, Model 2 produces 2.25 
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kg of biomass per batch, Model 3 produces 12,902.71 tablets per batch, and Model 4 produces 12,920.06 
tablets per batch. Figure 37 shows how the Capital Cost changes with the product failure rate for Model 
2. As the failure rate increases, the amount of capital cost charged to each kilogram of biomass produced 
increases. The lowest, for Model 2, is $24 thousand per kg of biomass produced.  
 Figure 38 shows how the Capital Cost changes with the product failure rate for Model 3. The 
lowest for Model 3 is $6.34 per tablet.  
 Figure 39 shows how the capital cost changes with the product failure rate for Model 4. The lowest 








Figure 39 Capital Cost per Tablet Model 4 
Figure 38 Capital Cost per Tablet Model 3 
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 Operating Cost per year 
The operating cost of a project includes costs that are related to the demand for a number of 
resources including raw materials, consumables, labor, heating/cooling utilities and power, as well as 
additional operational costs. Equation 6 shows how this number is calculated.  
Model 2 
Figure 40 displays how the Operating Cost changes with respect to the three variables: failure 
rate, media type and bioreactor type. Failure rate has a slight effect on the operating cost in this model. 
The costs increase slightly as the failure rate increases. The type of bioreactor used has a dramatic effect 
on the operational costs. Having all 4 bioreactors be reusable/sterilizable, increases costs by $7 million. 
This increase is seen because there is more cleaning involved which increases raw materials and utilities 
and power. Across the board, using CS media rather than FBS media reduces the operating costs because 
it is the less expensive option. However, there is only a slight difference in costs between completely 
Figure 40 Operating Costs per year for Model 2 
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disposable bioreactors and the 50/50 split. Disposable bioreactors have an operating cost of $11.6 million 
and the 50/50 split has an operational cost of $11.7 million.  
Table 13 Breakdown of Operating Costs for Model 2 The parameters used are: Disposable bioreactors, 
50% failure rate, FBS media 
Items $ % 
Raw Materials 1,112,000 8.77 
Labor-Dependent 4,181,000 32.96 
Facility Dependent 5,007,000 39.47 
Laboratory/QC/QA 627,000 4.94 
Consumables 1,748,000 13.78 
Waste Treatment/Disposal 1,000 0.01 
Utilities 6,000 0.05 




 Figure 41 shows how the operating costs change with respect to the three variables (failure rate, 
media type and bioreactor type) for Model 3. In this model, the failure rate has a more dramatic effect on 
Figure 41 Operating Costs per year Model 3 
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the operating costs. Across the board, as the failure rate increases the operating costs increase. The 
difference between 10% and 50% is between 900 thousand and 1 million dollars. The type of bioreactor 
has the most effect on the operating cost, while the media type has a smaller effect. Reusable/sterilizable 
bioreactors, at their lowest, have an operating cost of $22.8 million with FBS and $22.6 million with CS. 
50/50 bioreactors, at their lowest, have an operating cost $16.6 million with FBS and $16.4 million with 
CS. Disposable bioreactors, at their lowest, have an operating cost of $16.5 million with FBS and $16.3 
million with CS.  
Table 14 Breakdown of Operating Cost for Model 3: The parameters used are: 25% failure rate, FBS 
media, Reusable Bioreactors 
Items $ % 
Raw Materials 3,476,000 14.98 
Labor-Dependent 4,499,000 19.39 
Facility Dependent 8,061,000 34.73 
Laboratory/QC/QA 675,000 2.91 
Consumables 175,000 0.75 
Waste Treatment/Disposal 5,750,000 24.78 
Utilities 8,000 0.03 
Failed Product Disposal 564,000 2.43 
 
Model 4 
Figure 42 shows the operating costs for Model 4 and how it changes with respect to failure rate, 
media type, and bioreactor type. The failure rate has a similar effect on Model 4 as it did in Model 3. As 
the failure rate increases, the operating costs increase. The difference between 10% and 50% is between 
$900 thousand and $1 million across all scenarios. CS media lowers the operating costs, as opposed to 
FBS media, however the difference is not as dramatic as the type of bioreactor. Reusable/sterilizable 
bioreactors, at their lowest, have an operating cost of $21.4 million with FBS and $21.2 million with CS. 
50/50 split, at their lowest, have an operating cost of $14.7 million with FBS and $14.4 million with CS. A 
breakdown of the operating cost at their lowest is displayed in Table 8. Disposable bioreactors, at their 
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lowest, have an operating cost of $14.7 million with FBS and $14.5 million with CS. As opposed to Model 
3, Model 4 lowers the operating costs in all scenarios and the better option would be the 50/50 split.  
 
 
Table 15 Breakdown of Lowest Operating Cost The parameters are: 50/50 bioreactors, 10% failure rate, 
CS media for Model 4 
Items $ % 
Raw Materials 1,168,000 8.01 
Labor-Dependent 4,301,000 29.50 
Facility Dependent 6,356,000 43.60 
Laboratory/QC/QA 645,000 4.42 
Consumables 1,156,000 7.93 
Waste Treatment/Disposal 713,000 4.89 
Utilities 6,000 0.04 
Failed Product Disposal 233,000 1.60 
 
Figure 42 Operating Costs per year Model 4 
70 
 
Unit Production Cost 
 The unit production cost tells us how expensive it will be to make the product. Equation 7 lists 
how this number is calculated.   
 
 Model 2 
Model 2’s goal was to create biomass. The unit production cost is based on kg of biomass. Figure 43 shows 
how the Unit production cost for Model 2 changes with respect to the three variables: bioreactor type, 
media type, and failure rate. The failure rate has the most dramatic and direct effect on the unit 
production cost. When the failure rate increases, so does the unit production cost. When you compare 
the media type, CS comes out lower than FBS every time. When you compare the bioreactor type, 
reusable/sterilizable bioreactors range from $267,9700 – 482,426 per kg with FBS and $254,321 - 456,858 
per kg with CS. Disposable bioreactors range from $173,593- 312,557 per kg with FBS and $159,949 – 
287,988 per kg with CS. 50/50 split bioreactors range from $174,372- $313,950 per kg with FBS and 
$160,072- $289,382 per kg. Disposable bioreactors have a slightly lower unit production cost than the 






 Model 3 switches gears from Model 2 and turns the biomass into tablets. The unit production cost 
is now based on the cost per tablet. Figure 44 shows how the unit production cost changes for Model 3 
with respect to media type, failure rate, and bioreactor type. Again, failure rate as the most dramatic and 
direct effect on the unit production cost. As the failure rate increases, so does the production cost. When 
you compare media type, CS comes out lower than FBS every time. When you compare the bioreactor 
type, reusable/sterilizable bioreactors range from $56.27-105.28 per tablet with FBS and $55.83-104.49 
per tablet with CS. Disposable bioreactors range from $39.62-75.31 per tablet with FBS and $39.18-74.52 
per tablet with CS. 50/50 split bioreactors range from $39.75-75.55 per tablet with FBS and $39.31-74.76 
Figure 43 Unit Production Costs for Model 2 
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per tablet with CS. The lowest unit production cost occurs with disposable bioreactors and CS. However, 




 Model 4 the unit production cost, like Model 3, is based on cost to make a tablet. Figure 45 shows 
how the unit production cost changes for Model 4 with respect to media type, failure rate, and bioreactor 
type. Failure rate has a direct relationship with the unit production cost; as the failure rate increases, so 
does the unit production cost. When you compare media type, CS comes out lower than FBS across failure 
rate and media type. When you compare bioreactor type, reusable bioreactors range from $51.31-96.36 
per tablet with FBS and $50.78 – 95.40 per tablet with CS. Disposable bioreactors range from $35.18-67.32 
Figure 44 Unit Production Cost per tablet for Model 3 
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per tablet with FBS and $34.65-66.36 per tablet with CS. 50/50 split bioreactors range from $35.10-67.19 
per tablet with FBS and $34.58-66.25 per tablet with CS. This model has the lowest unit production cost 
with the 50/50 split scenario with CS, while disposable bioreactors are only pennies behind.  
 
 
Using a 10% failure rate, 50/50 bioreactors in Model 4 the unit cost is $34.58. Adding in $6 to help 
cover capital costs, the selling price for the tablet would be $40.58. This would give a return on investment 












 The experiments started out by growing Perkinsus marinus at 20 mL scale in T flasks and then 
scaling up ten-fold into a 400 mL (220 mL working volume) bioreactor.  
 The growth of Perkinsus was tracked using the absorbance measured at 600 nm. Generally, the 
absorbance increased by 0.1 – 0.2 A per day. There was some fluctuation depending on where in the 
growth cycle the sample was taken. Towards the end of the growth, the change in absorbance would be 
smaller due to Perkinsus slowing down in growth. An unusual jump in absorbance was an indication that 
the cultures became contaminated, which would then be confirmed by looking at the cultures under the 
microscope. With improving technique, by experiment 3 the growth of Perkinsus in the bioreactors was 
completed contamination-free. 
 Aeration became an issue at the very beginning of growing Perkinsus in the bioreactors. In 
Experiment 1, it was discovered that the air supply line was not hooked up to the reactors. Solving this 
issue took a top priority and once the airline was hooked up, the air sparger was inserted directly into the 
medium. Immersing the sparger caused the medium to instantly start foaming. Foaming of the media was 
caused by the tiny air bubbles from the sparger and gave a greater risk of contamination, since the foam 
could propagate into the peripheral connections on the bioreactor. There was a discussion of whether or 
not to add anti-foaming agents to the media to try to reduce the foaming of the media. We decided this 
was not the way to go due to the unknown effects the foaming agents could have on the cells. Ultimately, 
it was decided that the air would flow over the headspace and allow the oxygen to diffuse into the 
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medium. In Experiment 7, it was discovered that the air flow rate directly impacted the growth rate. A 
clogged air filter lowered the rate of aeration in Vessel 3, while the other three vessels maintained 3.5-4 
mL/s or 1.2-1.33 headspace vol/min.      
Despite improved technique and operating conditions, one of the biggest issues with the 
bioreactors was contamination of bacteria in the cultures, even with antibiotics already included in the 
media. The antibiotics used in the medium are penicillin G (100 U/mL) and streptomycin sulfate (100 
U/mL), which are standards in the cell culture industry. Once antibiotic-resistant bacteria enter the 
culture, it becomes a challenge to remove them from the nutrient rich medium. One possibility that could 
help with this issue would be to change or add different antibiotics to the medium.  
The cause of contamination could be from multiple sources. However, the most probable cause 
of contamination is from the sample ports. The boundary of sterility is breached once a sample is removed 
or if the sample port was not sterilized for the required time, or perhaps the required temperature was 
not achieved. There is also the possibility that the septum was not installed correctly allowing 
contamination. Another possibility is that there was an integrity breach of the gas filters. Due to the nature 
of glass, there could also be tiny cracks in the vessels themselves which could provide an environment 
which would allow bacteria to grow.  
After running multiple experiments, the redox curve started to show a characteristic shape for a 
clean, uncontaminated fermentation, which can be seen in Figures 9, 16, 22, 24. This redox response 
became useful as a real time indication of whether the fermentation vessels were contaminated or 
uncontaminated before looking at the cells under the microscope. Superimposing the growth curve over 
the redox curve, one can see that the injection of the inoculum leads to the redox becoming negative at 
the beginning of the experiment. There are a number of possibilities for the negative redox. The medium 
before inoculation may have a low volume of dissolved oxygen which would contribute to the negative 
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redox. The inoculum itself could be oxygen starved. The inoculum is grown in a T-flask which allows oxygen 
to enter the medium through a filter, but this is not controlled. In the bioreactors, as the cells grow and 
adjust to their new environment, the redox starts to turn positive. The air flow over the reactor surface 
enables oxygen the chance to dissolve into the medium to be used by the cells. The positive bump in the 
redox curve correlates to the exponential growth phase. However, this is counterintuitive to what we 
believe should be happening. As the cell grow, they should be using more oxygen which would correlate 
to the redox dropping.  As cell growth slows down, the redox curve drops again, but stays positive reaching 
an equilibrium type state. The cells have stopped growing due to running out of nutrients or space in the 
reactor.  
Once the redox started dipping down prominently or staying negative, which can be seen in 
Figures 5, 7, 12, 24, it became an indication to check the cultures for contamination. Looking at the 
cultures under the microscope would confirm that something else was growing in the fermentation vessel. 
Bacteria more often have a much quicker doubling time and use up the nutrients in the medium faster 
than Perkinsus uses them. They will also use the dissolved oxygen in the medium faster, which would 
contribute to the redox curve becoming negative and staying negative.  
Given our observations of apparent bacterial contamination in low redox fermentations, this 
biotic explanation of the low redox values seems reasonable. It may be possible that other chemical 
processes are at work creating the low redox fermentations, but to date we have not formulated an 
alternate hypothesis that could explain the observed behavior. 
  Using the HPLC to track the glucose concentration during fermentation led to some interesting 
results. The glucose concentration decreased more slowly than what was expected. The concentration 
only approached zero during contaminated runs (see Figure 25). This leads to the assumption that glucose 
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is not the limiting nutrient in the growth medium. But if glucose is not the limiting nutrient, what is? Is the 
limiting nutrient located in the serum? And if it is located in the serum, which molecule is it?  
Chicken Serum Optimization  
 One of the goals of this investigation was to look at all the medium ingredients to determine if 
there were any that could be replaced for a less expensive alternative. The most expensive ingredient per 
liter was FBS, which led to the question: what could replace FBS while still supplying the necessary 
nutrients that FBS contains? Looking through the literature, we found several possibilities that had the 
potential of working. Two possibilities discussed were coconut water (Shilpa, 2014) and egg yolks (Sasse, 
Lengwinat, Henklein, Hlinak, & Schade, 2000). There wasn’t much more investigation into coconut water 
as a replacement beyond the initial findings. It could still be a viable option to reduce costs.  
 One of the issues discovered with egg yolks was that it would often cause precipitation in the 
medium. Instead of egg yolks in the medium, Cornet used chicken serum as a replacement  for fetal bovine 
serum - in the growth of the bivalve primary cells, Mytilus galloprovincialis (Cornet, 2006). Mytilus 
galloprovincialis is a Mediterranean mussel. While there are many differences between an oysters and 
mussels, they are similar enough that this discovery led to more investigation into chicken serum as a 
possible replacement. I then uncovered a paper that grew Crassostrea virginica, the oyster host of 
Perkinsus, using chicken serum in the growth medium (Richards et al., 2018). This gave more evidence to 
the idea that chicken serum could be a replacement for fetal bovine serum for Perkinsus because it has 
been used to successfully grow its host cells.  
When the original media formulation was developed, 5% v/v FBS was determined to be the 
optimal concentration for cell growth. Higher concentrations of FBS were inhibitory (Gauthier & Vasta, 
1995). However, we were unsure if this dosage would be at the optimal concentration for CS. From the 
data displayed in Figure 19, we can see that 20% CS increases the growth more than 5% v/v CS does, while 
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lower levels of CS still showed some growth, but a smaller growth rate. This leads to the conclusion that 
5% v/v CS is the minimum percentage needed to achieve abundant growth, while a higher percentage can 
still be used. The higher percentages will increase the cost of the medium and diminish the advantage of 
using CS as a substitute for FBS. It comes down to the question, which is more important: growth or cost?
 Why does increasing the percentage of CS increase growth, while it’s known that if the percentage 
of FBS is increased, it inhibits growth (Gauthier & Vasta, 1995)? Three of the major glycoproteins of FBS 
are fetuin, albumin, and transferrin. Fetuin enhances growth, albumin has a slight positive effect on 
growth, and transferrin inhibits growth (Gauthier et al., 1995). What are the differences between CS and 
FBS? According to a sample certificate of analysis (COA) from Sigma Aldrich (which can be found in 
Appendix C), the concentration of albumin for both FBS and CS is 1.6 g/dL. The certificates do not list 
fetuin or transferrin for either serum.  Are there conformational changes in the proteins just enough that 
they align more closely with what Perkinsus needs? In terms of albumin, the structure of bovine albumin 
is listed on the RCSB Protein Data Bank, but the structure for chicken albumin is not listed. Fetuin is not 
listed for bovines or chickens. In the RCSB Protein Data Bank, transferrin structures can be found for both 
bovines and chickens. A structure comparison shows that diferric chicken serum transferrin (1N04) 
matches only a lactoferrin (1BLF) for bovines. While lactoferrins and transferrins have similar structures 
and functions, lactoferrins are found in milk, not serum. Currently the question of the differences between 
FBS and CS proteins remains as a hypothesis.  
 One of the differences found in the COA was the concentration of cholesterol. FBS has a 
concentration of 31 mg/dL while CS has a four-fold higher concentration of 130 mg/dL.  Another notable 
difference between the two serums is the concentrations of globulins. Present in CS is alpha 1 globulin 
(0.16 g/dL), alpha 2 globulin (0.33 g/dL), beta globulin (0.58 g/dL), and gamma globulin (0.29 g/dL). In 
comparison in FBS is alpha 2 globulin (1.3 g/dL), beta globulin (0.6g/dL) and gamma globulin (0.1 g/dL). 
FBS does not contain alpha 1 globulin. 
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 An important issue with serum, in general, is the batch-to-batch consistency. The above numbers 
are from a sample COA and may not reflect exactly with what was used during experiments. However, 
they do give a general idea of what some of the molecular differences are between FBS and CS.   
Genetic Variants 
 Experiment 7 compared the growth of PRA-240 wild-type to PRA-393 GFP mutant cells in the 
bioreactor with FBS medium. This experiment established that the genetic variant could grow in the 
bioreactor and the growth curve can be seen in Figure 21. 
 Experiment 8 compared the growth of PRA-393 GFP mutant cells in FBS medium and CS medium. 
This experiment established that the genetic variants can be grown in CS medium and the growth curve 
can be seen in Figure 23. 
Production Process Model 
 The model was built to expand on the knowledge gained from the experimental data and to test 
economic questions, like what is the optimal amount of CS to use? Lab scale production is not cost 
effective, however being able to scale up the process for vaccine production will make the production 
more cost effective.  
The failure rate in the model refers to the fraction of fermentation batches that are initiated but 
fail to grow or fail to meet required product standards, and was modeled as a percentage of the end 
product. The most likely cause of failure is likely to be contamination coming from bacteria during the 
fermentation steps. Disposable bioreactors reduce the chance of contamination happening. With the use 
of disposable bioreactors, there would be fewer wasted runs. In terms of money, the most cost-effective 
version of Model 4 was the 50/50 split with the first two bioreactors reusable and the second two 
bioreactors disposable. Other scenarios with the disposable bioreactors in the different sequences were 
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also looked at. However, the least expensive option across the board was with the first two bioreactors 
reusable and the second two disposable. One possible issue with this scenario is that SuperPro prices all 
disposable bioreactors at $221,000 with a volume of 700 L. The bag that gets replaced after each run costs 
$6,220. According to our results, the high costs (per unit production) associated with high failure rates 
suggests that that going completely disposable might be the better option in terms final of cost. 
One issue with bioreactor bags is that they have to be handled with care. Inspecting for failure 
rates of a one-use bag can be a challenge. Stainless steel bioreactors can be inspected for failure with a 
simple pressure test. In contrast, as soon as any pressure is introduced to a bag, it will inflate like a balloon. 
So likely the fermentation facility will depend in the quality control of the provider of the disposable 
reactor. 
Model 4 was used to determine what the optimal amount of chicken serum would be. When all 
the economics were configured, Equation 1 was used. Serum was not separated out in the equation. In 
order to address this, the stoichiometric equation was changed to Equation 9.  
0.83𝑀 𝐶𝑆 𝑀𝑒𝑑𝑖𝑎 + 0.56 𝑆𝑒𝑟𝑢𝑚 + 1𝑀 𝑂2 + 1𝑀 𝑁2 →
0.02𝑀 C𝐻1.8𝑂0.5𝑁0.2  + 0.62𝑀 𝐶𝑂2 + 0.31𝑀 𝐶3𝐻6𝑂3 + 1.64𝑀 𝐻20  (9)
 
The media formulation was then set to 5% in the 50/50 bioreactor scenario with a 10% failure rate. The 
difference between a concentration of 20% and 5% CS was 15 tablets per batch. All the economics for 
20% CS increased from where 5% CS is. According to the model, 5% CS is the optimal concentration. 
 There are some issues with the model that should be addressed. One issue is that when assessing 
the economics of the model, costs of materials I used were lab scale numbers. For example, the cost of 
FBS media per liter is $123.30 and the cost of CS media per liter is $48.00. Most likely these numbers 
would decrease upon scaling up. Thus, the operating costs and raw material costs may actually go down 
from what’s been reported with the model.  
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 Another issue with the model is what further processing will be required after Perkinsus has 
finished growing. In this model we assumed that the cells would be have to be killed before being turned 
into a tablet. However, it may be that the cells may need to be alive for vaccine delivery, which would 
greatly complicate storage, transport and raise the cost considerably for effective distribution and delivery 
of the vaccine. Alternatively, the therapeutic proteins might need to be extracted from the cells before 
being turned into a tablet. Ideally, the vaccine could be administered orally, which is why we chose to use 
tablets as a final product, but it’s also possible that the vaccine may need to be delivered as a shot. Since 
the development of therapeutic proteins using Perkinsus is still far from practical implementation, details 
on these aspects of final drug development have been presented as one of several possible final 
configurations.   
Another improvement that can be made to the model is that the exact chemical formula for 
Perkinsus was not used for determining cell growth, which was modeled as a stoichiometric reaction. I 
used the built-in biomass composition as a substitute for not knowing the exact chemical composition. I 
also used a very simple reaction (Equation 1) for simulating the fermentation. This reaction can be further 







CONCLUSIONS AND FUTURE WORK 
Conclusions 
It is possible to grow Perkinsus marinus in bioreactors. Both wild type and modified cultures were 
successfully grown.  
Sufficient aeration can be achieved by sweeping the void space with a fresh supply of air and maintaining 
moderate stirring. 
Redox measurements are useful for real-time detection of bacterial contamination. 
Chicken serum is an effective and less expensive replacement for FBS. 
Failure rates in fermentation production appear to be the most significant operational risk to cost of 
production.   
Based on economic estimates embedded in SuperPro, cost of growing Perkinsus cell mass could cost from 











Determine what proteins are present in CS and which ones actually help Perkinsus. 
Determine if CS has to undergo more vigorous testing to be used in pharmaceuticals.  
HPLC- determine if there are any matrix effects; deproteinize the samples and then run through again  
Accurately determine what the limiting nutrient is in the media. 
Upscale even further (1L, 4L, etc.)—anticipated issues: Aeration scale up? Contamination? Move to 
disposable reactors? 
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Appendix A. Experimental Data 
Dry Weight 
 Due to the small sample sizes, there is a lack of precision in the data for dry weight and percent 
















Figure 46 Scatter Plot of Dry weight vs Absorbance. Regression line equation: y = 2.956x with an 




Figure 47 Scatter Plot of Dry Weight Broken Down by Cell Type. GFP regression line: y = 2.246x with r2 = 
85.2% WT regression line: y = 2.046x with r2= 88.3% 
 
Ash in Biomass 
Table 16 Percentage of Ash in Biomass 















Standard deviation all: 20.9 
Standard deviation WT: 25.1 




Appendix B. Extra Model Graphs 
 





Figure 49 DFC Model 2 
 
 


























USA origin, sterile-filtered, suitable for cell culture 
Product Number C5405 
Product Brand SIGMA 
  
TEST SPECIFICATION LOT 12M494 RESULTS 
Cell Lines Record cell lines Sp2/0 cell line 
Sterility No microbial growth detected No microbial growth detected 
Mycoplasma None detected (Broth Culture) None detected 
Osmolality 285 - 340 mOsm/kg H2O 295 mOsm/kg H2O 
Location of Reserve Sample Present 3 X 100mL in QC Retain Bin #4096 
Total Protein 2.0 - 4.3 g% 3.0 g% 
Chemical Profile Cholesterol - Report result (mg/dL) 130 mg/dL 
  Iron - Report result (mcg/dL) 119 mcg/dL 
  Glucose - Report result (mg/dL) 196 mg/dL 
  Sodium - Report result (mEq/L) 137 mEq/L 
  Triglyceride - Report result (mg/dL) 46 mg/dL 
Electrophoretic Profile Albumin (g/dL) - Record 1.6 g/dL 
  Alpha 1 Globulin (g/dL) - Record 0.16 g/dL 
  Alpha 2 Globulin (g/dL) - Record 0.33 g/dL 
  Beta Globulin (g/dL) - Record 0.58 g/dL 
  Gamma Globulin (g/dL) - Record 0.29 g/dL 
Mycoplasma 
None detected (DNA Fluorochrome 
Stain) 
None detected 
pH 7.0 - 8.2 7.8 
Ouchterlony Species Identification Satisfactory Satisfactory 
Endotoxin <= 50 EU/mL 1 EU/mL 
Hemoglobin Test <= 60 mg% 32 mg% 
Serum Performance Test Comparable to control lot Comparable to control lot 
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Country of Origin Record country of origin United States 
Appearance Clear straw to amber colored liquid Clear amber colored liquid 
      
COMMENTS 
  
      
C of A comments 
 Country of final product processing: 
United States 
Origin 
 The materials used in this product 
were collected in the United States. 
Storage 
 
Store at -20 C 
  
 For R&D use only. Not for drug, 
household, or other uses. 




























Fetal Bovine Serum, 
USA origin, sterile-filtered, suitable for cell culture, suitable for hybridoma 
Product Number F2442 
Product Brand SIGMA 
  
TEST SPECIFICATION LOT 18N103 RESULTS 
Endotoxin <= 10 EU/mL 0.2 EU/mL 
Mycoplasma None detected (Broth Culture) None detected 
Osmolality 260 - 340 mOsm/kg H2O 304 mOsm/kg H2O 
AVA (9CFR113.53) 
Bovine Adenovirus (type 3 and 5) -
,None detected 
None detected 
  Bovine Parvovirus - None detected None detected 
  Blue Tongue Virus - None detected None detected 
  BVDV by FA - Tested Tested 
  Cytopathic Effect - None detected None detected 
  Hemadsorption - None detected None detected 
  
Infectious Bovine Rhinotracheitis - 
None,detected 
None detected 
  Parainfluenza 3 - None detected None detected 
  Rabies Virus - None detected None detected 
  Reovirus - None detected None detected 
  




Vesicular Stomatitis Virus -,None 
detected 
None detected 
Bacteriophage Testing Record (PFU/mL) 54 PFU/mL 
Total Protein 3.0 - 4.5 g% 3.5 g% 
Chemical Analysis Cholesterol - Report result 31 mg/dL 
Hormone Level Estradiol - Report result 20.1 pg/mL 
Chemical Analysis Iron - Report result 150 mcg/dL 
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  Glucose - Report result 120 mg/dL 
Hormone Level Insulin - Report result 0.9 mcIU/mL 
Chemical Analysis Sodium - Report result 133 mEq/L 
Hormone Level Progesterone - Report result <0.1 ng/mL 
Sterility per current USP Negative Negative 
Hormone Level Testosterone - Report result 11 ng/dL 
Tetracycline Report Result None detected 
Chemical Analysis Triglyceride - Report result 72 mg/dL 
Serum Antibody Titer - BRSV Report result < 1:2 
Serum Antibody Titer - BVDV Report result 1:2 
Serum Antibody Titer - IBR Report result < 1:2 
Serum Antibody Titer - PI3 Report result < 1:2 
Cloning Assay Pass Pass 
Mycoplasma 
None detected (DNA Fluorochrome 
Stain) 
None detected 
Insect Cell Culture Test Min CD 1.2X10E6, Max DT 33.5 hr CD 3.1X10E6, DT 24.3 hr 
Cell Lines Record cell lines used Sf9 cell line 
pH 6.7 - 8.0 7.2 
Bovine IgG <= 1 mg/mL 0.09 mg/mL 
Serum Performance Test Pass Pass 
Cell Lines Record Cell Lines Used FIO BHK-21 cell line 
Hemoglobin <= 20 mg% 17 mg% 
Electrophoric Profile Albumin - Report Result 1.6 g/dL 
  Alpha 1 Globulin - Report result 0.0 g/dL 
  Alpha 2 Globulin - Report result 1.3 g/dL 
  Beta Globulin - Report result 0.6 g/dL 
  Gamma Globulin - Report result 0.1 g/dL 
Country of Origin Record United States 
Appearance Clear straw to amber colored liquid Clear amber colored liquid 
      
COMMENTS 
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C of A comments 
 Country of final product processing: 
United States 
Intended Use 
 For R&D use only. Not for drug, 
household, or other uses. 
Origin 
 The material used in this product 
was collected in the United States. 
  
 
Animals used for collection of serum 







Store at -20 C 




























Appendix D. DAS-GIP System How To 
Step 1: Turn everything on 
a) There are 3 switches behind the monitors for DAS-GIP 
b) The computer and computer monitor  
1. The password to turn on the computer is 06maine08 
2. The password for DAS-GIP is dasgip.  
Step 2: Once DAS-GIP is open, Click on File and then New Work Flow 
Step 3:  The New Work Flow Box should pop open with two tabs 
 Tab 1: Based on Template  
a) Select the type of control system you want for your experiment: pH control acid/base, pH 
control acid, pH control base or pH-measurement; all have temperature control 
b) Select the number of reactors you plan to use for the experiment (1-4) 
1. If you plan to use less than 4 reactors unplug the pH sensors pH4RD4 that won’t be in 
use. Otherwise, you will get an error message when you calibrate the pH sensors 
Tab 2: Based on Previous Work flow 
a) Click on your previous experiment  
b) if you want an exact copy, check the box, if not then select the number of reactors 
Step 4: Open the work Flow 
a) Decide which calibration procedures need to be done: pH, pump, CIP, temperature 
1. pH calibration is always check marked 
2. pump and CIP only need to be done if the pumps and feed lines are being used in 
the work flow 
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3. Temperature calibration should be done if you think something is wrong with the 
temp probes 
b) Click Finish  
c) A box will ask if you want to save changes, click yes 
Step 5:  Set up the requirements of the experiment 
a) Set the time of the experiment. It’s preset for 24 hours but can be lengthened or shortened 
depending on what your needs are 
b) Set the Temperature for each reactor individually  
1. Double Click on the box displaying the temperature (it’s preset to 37°C) 
2. In the Tab labeled Profile Set up 1, T click on Data then enter your desired 
temperature 
3. Repeat for all the reactors that need a temperature change 
c) Change the Rate of stirring individually 
1. Double click on the box displaying the stirring (it’s preset to 400rpm) 
2. In the Tab labeled Profile Set up 1, N click on Data and enter the desired stir rate 
3. Repeat for all reactors 
d) If you are adding things via the feed tubes, use the Substrate A and B boxes to control what is 
being added to the reactors; how it’s added, what the triggers are, etc. 
e) Once everything is organized click Finish 
f) A box will pop up asking if you want to save, click OK 
 
Step 6: pH Calibration 
a) A box will pop up asking if you want to start the pH calibration. Click Yes 
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b) The preset buffer solutions are 7 and 4, but can be changed if needed 
1. Immerse ALL the pH sensors into the 1st buffer [generally pH 7] 
2. Wait until all the readings are stable 
3. Click Start; yellow rings indicate calibration in progress 
4. Wait until all rings are blue and message reads “Ready 1” 
5. Rinse off all pH sensors with DI water and pat dry 
6. Immerse ALL the pH sensors into the 2nd buffer [generally pH 4] 
7. Wait until all the readings are stable 
8. Click Start 
9. Wait until all rings change from yellow to green and message reads “Ready 2” 
10. Recheck calibration by putting the sensors back into first buffer 
c) Click Finish to Leave  
d) A box will pop up if asking if you are finished, click yes 
Step 7: Autoclave 
a) A box will pop up asking if you want to continue with procedure control. Click NO. 
b) Prepare all vessels for the autoclave 
1. Cover all sensors with caps 
2. Cover all filters with aluminum foil 
3. Place the magnetic stir bars in the vessel far away from the housing [the magnet is very 
strong and will break the vessel] 
4. Make sure all entrances are sealed 
5. Autoclave the vessels with/without medium [depends on the medium you are using]. 




6. Let the vessels cool down completely before use [I let them cool down over night] 
Step 8: Prepare the system 
a) Once vessels are cooled down; add the medium to the vessel if you have not done so already 
b) Inoculate the vessels under a clean hood  
c) Make sure everything is turned on 
d) Hook up Each Vessel one by one 
1. Insert the grounding line [green and yellow] into the top of the vessel 
2. Hook up the Redox [solid color] and pH [grey stripe above the solid color] probes; the 
colors should match each other 
3.  Hook up the water to the condenser [red line goes on top; blue line goes on bottom] 
4. Insert the Air line into the air filter 
5. Turn on the air; the valve is located in bay B 
6. At the back of the housing, open the water lines for each vessel  
7. Repeat for all Vessels 
8. Turn on the Water 
Step 9: Start the Work Flow  
a) Open DAS-GIP control 
b) Under Waiting; you’ll find your work flow 
c) Right Click on your work Flow and Select Run  
d) The control page will pop open 
e) You can trigger each even individually or all at once (I tended to trigger each even individually) 
1. Turn on temperature control by clicking the X next to T 
2. Turn on the stir bar by clicking the X next to SC 
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3. If using, trigger A and B by clicking on the X next to them  
4. Trigger Inoculation Run Time by clicking the X next to Ino. 
f) Once everything is triggered you can toggle between values to keep an eye on things, but for the 
most part you can leave it alone. The computer knows what it’s doing 
g) Take samples as often as you need to depending on your experiment 
Step 10: Finish the work Flow  
a) Once the experiment is complete click FINISH in the top right corner 
b) A box will pop up asking if you are sure, click yes 
c) Your work flow will move from Waiting to Finished 
d) Right Click on the work flow and click on Export (ZIP)  
1. The file will be exported to a file on the desktop labeled “DASGIP Export” 
2. You can move the file to a different location or leave it 
3. There will be 3 different files in the zip file 
a. [your work flow].control will have all the information from the experiment  
b.  [your work flow] just gives basic information about the work flow 
c. [your work flow].pH Calibration gives the calibration information 
4. Export the Zip File and Open [your work flow].Control  
a. Once the file is open it will give you the option to create graphs 
b. All the data will be separated by having each reactor in different tab 
c. When you save the file, save it as a Microsoft Excel Worksheet so that it will be 
compatible with newer versions of Excel 




Step 11: Clean Up 
a) Dispose of everything properly (biohazards do not go down the drain) 
b) Clean out the vessels 
c) Unhook everything, store probes properly 
d) Turn off DASGIP 
























Appendix E. Model Information 
 
Table 17 Model 2 All Disposable Bioreactors Info 
Label Operations Changes to Default Scheduling Start Times 
P-2/V-101 Charge-1 Volume = 20 mL Beginning of batch 
  Agitate-1 Default Settings Relative to end of charge-1  
  Transfer-Out-1 100% of vessel contents Relative to end of agitate-1 
      
P-3/DE-101 Filter-1 Default settings Relative to end of transfer out-1 in P-2 
      
P-1/ TRF-101 Transfer-In-1 Default settings Relative to end of Filter-1 in P-3 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Charge-1 
   Heat Agent = Hot Water   
  Ferment-1 Final Temp = 28° C Relative to end of Heat-1 
   Heat Transfer Agent = Cooled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Cooled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
      
P-6/V-102 Charge-1 V = 200 mL Relative to end of Cool-1 in P-1 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate -1 
      
P-7/ DE-102 Filter-1  Default settings Relative to end of Transfer-Out-1 in P-6 
      
P-4 / DBS-
101 Transfer-In-1 Default Settings Relative to end of Ferment in P-1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to end of Ferment-1 
   Cooling Agent = Chilled Water   




Table 17 Continued 1 
P-5/AF 101 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-4/DBS-101 
      
P-9/V103 Charge-1 V = 4L Relative to end of Cool-1 in P-4 
  Agitate-1 Default Settings Relative to end of Charge 1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-10/DE-103 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-9 
      
P-8/ DBS 102 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-10 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-11/AF-102 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-8/DBS-102 
P-12/V-104 Charge-1 V = 80L Relative to end of Cool-1 in P-8 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-15/DE-104 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-12 
      
P-13/DBS-
103 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-15 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   




Table 17 Continued 2 
P-14/AF-103 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-13/DBS-103 
P-18/V-105 Charge-1 V = 1600L Relative to end of Cool-1 in P-13 
  Agitate-1 Default Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-19/DE105 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-18 
      
P-16/DBS 
104 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-19 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-17/AF104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-16/DBS-104 
P-21/DC-101 Centrifuge-1 Equipment based on Solids Removal Relative to end of Transfer-Out-1 in P16 
   Solids Concentration in Stream = 1000g/L   
  SIP-1 (steam in place) Default Settings   
      
P-30/ ST-101 Sterilize-1 Default Settings Relative to end of Centrifuge-1 in P-21 
      
P-20/ FDR-
101 Transfer-In-1 Default Settings Relative to end of Centrifuge-1 in P-21 
  Dry-1 Final LOD = 0.01 Relative to end of Transfer-In-1 
   FBS, Lactic Acid, and Water set to be volatile   
  Transfer-Out-1 100% of vessel contents Relative to end of Dry-1 
  CIP-1 Uses NaOH(2M)   






Table 18 Model 2 50/50 Split bioreactors Info 
Label Operations Changes to Default Scheduling Start Times 
P-2/V-101 Charge-1 Volume = 20 mL Beginning of batch 
  Agitate-1 Default Settings Relative to end of charge-1  
  Transfer-Out-1 100% of vessel contents Relative to end of agitate-1 
      
P-3/DE-101 Filter-1 Default settings Relative to end of transfer out-1 in P-2 
      
P-1/ TRF-101 Transfer-In-1 Default settings Relative to end of Filter-1 in P-3 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Charge-1 
   Heat Agent = Hot Water   
  Ferment-1 Final Temp = 28° C Relative to end of Heat-1 
   Heat Transfer Agent = Cooled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Cooled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
      
P-6/V-102 Charge-1 V = 200 mL Relative to end of Cool-1 in P-1 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate -1 
      
P-7/ DE-102 Filter-1  Default settings Relative to end of Transfer-Out-1 in P-6 
      
P-4 / DBS-
101 Transfer-In-1 Default Settings Relative to end of Ferment in P-1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to end of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
  CIP-1 NaOH(2M)   
   Waste disposable = $50 per kg   




Table 18 Continued 1 
P-5/AF 101 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-4/DBS-101 
      
P-9/V103 Charge-1 V = 4L Relative to end of Cool-1 in P-4 
  Agitate-1 Default Settings Relative to end of Charge 1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-10/DE-103 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-9 
      
P-8/ DBS 102 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-10 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste disposable = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-11/AF-102 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-8/DBS-102 
P-12/V-104 Charge-1 V = 80L Relative to end of Cool-1 in P-8 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-15/DE-104 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-12 
      
P-13/DBS-
103 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-15 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
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Table 18 Continued 2 
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-14/AF-103 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-13/DBS-103 
P-18/V-105 Charge-1 V = 1600L Relative to end of Cool-1 in P-13 
  Agitate-1 Default Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-19/DE105 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-18 
      
P-16/DBS 
104 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-19 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-17/AF104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-16/DBS-104 
P-21/DC-101 Centrifuge-1 Equipment based on Solids Removal Relative to end of Transfer-Out-1 in P16 
   Solids Concentration in Stream = 1000g/L   
  SIP-1 (steam in place) Default Settings   
      
P-30/ ST-101 Sterilize-1 Default Settings Relative to end of Centrifuge-1 in P-21 
      
P-20/ FDR-
101 Transfer-In-1 Default Settings Relative to end of Centrifuge-1 in P-21 
  Dry-1 Final LOD = 0.01 Relative to end of Transfer-In-1 
   FBS, Lactic Acid, and Water set to be volatile   
  Transfer-Out-1 100% of vessel contents Relative to end of Dry-1 
  CIP-1 Uses NaOH(2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
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Table 19 Model 2 All Reusable Info 
Label Operations Changes to Default Scheduling Start Times 
P-2/V-101 Charge-1 Volume = 20 mL Beginning of batch 
  Agitate-1 Default Settings Relative to end of charge-1  
  Transfer-Out-1 100% of vessel contents Relative to end of agitate-1 
      
P-3/DE-101 Filter-1 Default settings Relative to end of transfer out-1 in P-2 
      
P-1/ TRF-101 Transfer-In-1 Default settings Relative to end of Filter-1 in P-3 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Charge-1 
   Heat Agent = Hot Water   
  Ferment-1 Final Temp = 28° C Relative to end of Heat-1 
   Heat Transfer Agent = Cooled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Cooled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
      
P-6/V-102 Charge-1 V = 200 mL Relative to end of Cool-1 in P-1 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate -1 
      
P-7/ DE-102 Filter-1  Default settings Relative to end of Transfer-Out-1 in P-6 
      
P-4 / DBS-
101 Transfer-In-1 Default Settings Relative to end of Ferment in P-1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to end of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
  CIP-1 NaOH(2M)   
   Waste disposable = $50 per kg   




Table 19 Continued 1 
P-5/AF 101 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-4/DBS-101 
      
P-9/V103 Charge-1 V = 4L Relative to end of Cool-1 in P-4 
  Agitate-1 Default Settings Relative to end of Charge 1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-10/DE-103 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-9 
      
P-8/ DBS 102 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-10 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste disposable = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-11/AF-102 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-8/DBS-102 
P-12/V-104 Charge-1 V = 80L Relative to end of Cool-1 in P-8 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-15/DE-104 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-12 
      
P-13/DBS-
103 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-15 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   






Table 19 Continued 2 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste disposable = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-14/AF-103 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-13/DBS-103 
P-18/V-105 Charge-1 V = 1600L Relative to end of Cool-1 in P-13 
  Agitate-1 Default Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-19/DE105 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-18 
      
P-16/DBS 
104 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-19 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste disposable = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-17/AF104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-16/DBS-104 
P-21/DC-101 Centrifuge-1 Equipment based on Solids Removal Relative to end of Transfer-Out-1 in P16 
   Solids Concentration in Stream = 1000g/L   
  SIP-1 (steam in place) Default Settings   
      




Table 19 Continued 3 
P-20/ FDR-
101 Transfer-In-1 Default Settings Relative to end of Centrifuge-1 in P-21 
  Dry-1 Final LOD = 0.01 Relative to end of Transfer-In-1 
   FBS, Lactic Acid, and Water set to be volatile   
  Transfer-Out-1 100% of vessel contents Relative to end of Dry-1 
  CIP-1 Uses NaOH(2M)   

























Table 20 Model 3 All Disposable Info 
Label in 
Model Operations Changes to Default Scheduling Start Times 
P-2/V-101 Charge-1 Volume = 20 mL Beginning of batch 
  Agitate-1 Default Settings Relative to end of charge-1  
  Transfer-Out-1 100% of vessel contents Relative to end of agitate-1 
      
P-3/DE-101 Filter-1 Default settings Relative to end of transfer out-1 in P-2 
      
P-1/ TRF-101 Transfer-In-1 Default settings Relative to end of Filter-1 in P-3 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Charge-1 
   Heat Agent = Hot Water   
  Ferment-1 Final Temp = 28° C Relative to end of Heat-1 
   Heat Transfer Agent = Cooled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Cooled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
      
P-6/V-102 Charge-1 V = 200 mL Relative to end of Cool-1 in P-1 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate -1 
      
P-7/ DE-102 Filter-1  Default settings Relative to end of Transfer-Out-1 in P-6 
      
P-4 / DBS-101 Transfer-In-1 Default Settings Relative to end of Ferment in P-1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to end of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
      
P-5/AF 101 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-4/DBS-101 
      
P-9/V103 Charge-1 V = 4L Relative to end of Cool-1 in P-4 
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  Agitate-1 Default Settings Relative to end of Charge 1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-10/DE-103 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-9 
      
P-8/ DBS 102 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-10 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-11/AF-102 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-8/DBS-102 
P-12/V-104 Charge-1 V = 80L Relative to end of Cool-1 in P-8 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-15/DE-104 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-12 
      
P-13/DBS-103 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-15 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-14/AF-103 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-13/DBS-103 
P-18/V-105 Charge-1 V = 1600L Relative to end of Cool-1 in P-13 
  Agitate-1 Default Relative to end of Charge-1 
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  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-19/DE105 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-18 
      
P-16/DBS 104 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-19 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-17/AF104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-16/DBS-104 
P-21/DC-101 Centrifuge-1 Equipment based on Solids Removal Relative to end of Transfer-Out-1 in P16 
   Solids Concentration in Stream = 1000g/L   
  SIP-1 (steam in place) Default Settings   
      
P-30/ ST-101 Sterilize-1 Default Settings Relative to end of Centrifuge-1 in P-21 
      
P-20/ FDR-
101 Transfer-In-1 Default Settings Relative to end of Centrifuge-1 in P-21 
  Dry-1 Final LOD = 0.01 Relative to end of Transfer-In-1 
   FBS, Lactic Acid, and Water set to be volatile   
  Transfer-Out-1 100% of vessel contents Relative to end of Dry-1 
  CIP-1 Uses NaOH(2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
     
     
      
P-22/NM-101 Nano-Mill-1 Default Settings Relative to End of Transfer-Out-1 in P-20 
  CIP-1 Default Settings   
  SIP-1 Default Settings Relative to End of CIP 
      
P-23/V-106 Charge-1 Mass = 5 kg Relative to Start of Nano-Mill-1 in P22 
  Charge-3 Mass = 20 kg Relative to end of Charge-1 
  Charge-2 Mass = 5 kg Relative to end of Charge-3 
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Transfer-In-1 Default settings Relative to end of Charge-2 
 Agitate-1 Default Settings Relative to end of Transfer-In-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default settings Relative to end of Transfer-Out-1 
      
P-24/GRN-
101 Granulate-1 Water is volatile, 5% Final LOD Relative to end of Transfer-Out-1 in P23 
  SIP-1 Default Settings Relative to end of Granulate-1 
      
P-25/V-107 Transfer-In-1 Default Settings Relative to end of Granulate-1 in P24 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Store-1 
      
P-26/TP-101 Tablet-1 Default Settings Relative to end of Transfer-Out-1 in P25 
  CIP-1 NaOH (2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-27/DB-101 Transfer-In-1 Default Settings Relative to end of Tablet-1 in P26 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  Transfer-Out-1 Default Settings Relative to end of Store-1 
      
P-29/V-108 Charge-1 Mass = 48 kg Relative to end of Tablet-1 in P26 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Pull-Out Set by Mast-Slave Relationship Relative to start of Coat-1 in P-28 
   Operation: Coat-1 in P28   
      
P-28 Transfer-In-1 Default Settings Relative to end of Transfer-Out-1 in P27 
  Coat-1 Default Settings; 4 cycles Relative to end of Transfer-In 










Table 21 Model 3 50/50 Info 
Label Operations Changes to Default Scheduling Start Times 
P-2/V-101 Charge-1 Volume = 20 mL Beginning of batch 
  Agitate-1 Default Settings Relative to end of charge-1  
  Transfer-Out-1 100% of vessel contents Relative to end of agitate-1 
      
P-3/DE-101 Filter-1 Default settings Relative to end of transfer out-1 in P-2 
      
P-1/ TRF-101 Transfer-In-1 Default settings Relative to end of Filter-1 in P-3 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Charge-1 
   Heat Agent = Hot Water   
  Ferment-1 Final Temp = 28° C Relative to end of Heat-1 
   Heat Transfer Agent = Cooled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Cooled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
      
P-6/V-102 Charge-1 V = 200 mL Relative to end of Cool-1 in P-1 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate -1 
      
P-7/ DE-102 Filter-1  Default settings Relative to end of Transfer-Out-1 in P-6 
      
P-4 / DBS-
101 Transfer-In-1 Default Settings Relative to end of Ferment in P-1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to end of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
  CIP-1 NaOH(2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
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    Set by Master-Slave Relationship 
P-5/AF 101 Filter-1 Default Operation: Ferment-1 in P-4/DBS-101 
      
P-9/V103 Charge-1 V = 4L Relative to end of Cool-1 in P-4 
  Agitate-1 Default Settings Relative to end of Charge 1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-10/DE-103 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-9 
      
P-8/ DBS 102 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-10 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-11/AF-102 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-8/DBS-102 
P-12/V-104 Charge-1 V = 80L Relative to end of Cool-1 in P-8 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-15/DE-104 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-12 
      
P-13/DBS-
103 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-15 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
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  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
  Cooling Agent = Chilled Water  
 Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-14/AF-103 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-13/DBS-103 
P-18/V-105 Charge-1 V = 1600L Relative to end of Cool-1 in P-13 
  Agitate-1 Default Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-19/DE105 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-18 
      
P-16/DBS 
104 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-19 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
      
P-17/AF104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-16/DBS-104 
P-21/DC-101 Centrifuge-1 Equipment based on Solids Removal Relative to end of Transfer-Out-1 in P16 
   Solids Concentration in Stream = 1000g/L   
  SIP-1 (steam in place) Default Settings   
      
P-30/ ST-101 Sterilize-1 Default Settings Relative to end of Centrifuge-1 in P-21 
      
P-20/ FDR-
101 Transfer-In-1 Default Settings Relative to end of Centrifuge-1 in P-21 
  Dry-1 Final LOD = 0.01 Relative to end of Transfer-In-1 
   FBS, Lactic Acid, and Water set to be volatile   
  Transfer-Out-1 100% of vessel contents Relative to end of Dry-1 
  CIP-1 Uses NaOH(2M)   




Table 21 Continued 3 
P-22/NM-
101 Nano-Mill-1 Default Settings Relative to End of Transfer-Out-1 in P-20 
  CIP-1 Default Settings   
  SIP-1 Default Settings Relative to End of CIP 
      
P-23/V-106 Charge-1 Mass = 5 kg Relative to Start of Nano-Mill-1 in P22 
  Charge-3 Mass = 20 kg Relative to end of Charge-1 
  Charge-2 Mass = 5 kg Relative to end of Charge-3 
  Transfer-In-1 Default settings Relative to end of Charge-2 
  Agitate-1 Default settings Relative to end of Transfer-In-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default settings Relative to end of Transfer-Out-1 
      
P-24/GRN-
101 Granulate-1 Water is volatile, 5% Final LOD Relative to end of Transfer-Out-1 in P23 
  SIP-1 Default Settings Relative to end of Granulate-1 
      
P-25/V-107 Transfer-In-1 Default Settings Relative to end of Granulate-1 in P24 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Store-1 
      
P-26/TP-101 Tablet-1 Default Settings Relative to end of Transfer-Out-1 in P25 
  CIP-1 NaOH (2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-27/DB-101 Transfer-In-1 Default Settings Relative to end of Tablet-1 in P26 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  Transfer-Out-1 Default Settings Relative to end of Store-1 
      
P-29/V-108 Charge-1 Mass = 48 kg Relative to end of Tablet-1 in P26 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Pull-Out Set by Mast-Slave Relationship Relative to start of Coat-1 in P-28 
   Operation: Coat-1 in P28   
      
P-28 Transfer-In-1 Default Settings Relative to end of Transfer-Out-1 in P27 
  Coat-1 Default Settings; 4 cycles Relative to end of Transfer-In 





Table 22 Model 3 Reusable Info 
Label Operations Changes to Default Scheduling Start Times 
P-2/V-101 Charge-1 Volume = 20 mL Beginning of batch 
  Agitate-1 Default Settings Relative to end of charge-1  
  Transfer-Out-1 100% of vessel contents Relative to end of agitate-1 
      
P-3/DE-101 Filter-1 Default settings Relative to end of transfer out-1 in P-2 
      
P-1/ TRF-101 Transfer-In-1 Default settings Relative to end of Filter-1 in P-3 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Charge-1 
   Heat Agent = Hot Water   
  Ferment-1 Final Temp = 28° C Relative to end of Heat-1 
   Heat Transfer Agent = Cooled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Cooled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
      
P-6/V-102 Charge-1 V = 200 mL Relative to end of Cool-1 in P-1 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate -1 
      
P-7/ DE-102 Filter-1  Default settings Relative to end of Transfer-Out-1 in P-6 
      
P-4 / DBS-
101 Transfer-In-1 Default Settings Relative to end of Ferment in P-1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to end of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to end of Cool-1 
  CIP-1 NaOH(2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
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 P-5/AF101 Filter-1 Default Set by Master-Slave Relationship 
   Operation: Ferment-1 in P-4/DBS-101 
      
P-9/V103 Charge-1 V = 4L Relative to end of Cool-1 in P-4 
  Agitate-1 Default Settings Relative to end of Charge 1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-10/DE-103 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-9 
      
P-8/ DBS 102 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-10 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-11/AF-102 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-8/DBS-102 
P-12/V-104 Charge-1 V = 80L Relative to end of Cool-1 in P-8 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-15/DE-104 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-12 
      
P-13/DBS-
103 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-15 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
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Table 22 Continued 2 
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
  Cooling Agent = Chilled Water  
 Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-14/AF-103 Filter-1 Default Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-13/DBS-103 
P-18/V-105 Charge-1 V = 1600L Relative to end of Cool-1 in P-13 
  Agitate-1 Default Relative to end of Charge-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
      
P-19/DE105 Filter-1 Default Settings Relative to end of Transfer-Out-1 in P-18 
      
P-16/DBS 
104 Transfer-In-1 Default Settings Relative to End of Filter-1 in P-19 
  Transfer-In-2 Default Settings Relative to End of Transfer-In-1 
  Heat-1 Final Temp = 28° C Relative to End of Transfer-In-2 
   Heat Agent = Hot Water   
  Agitate-1 Agitation Time = 8 days Relative to End of Heat-1 
  Ferment-1 Final Temp = 28° C Relative to Start of Agitate-1 
   Heat Transfer Agent = Chilled Water   
   Time = 8 days   
  Cool-1 Final Temp = 20° C Relative to End of Ferment-1 
   Cooling Agent = Chilled Water   
  Transfer-Out-1 100% of vessel contents Relative to End of Cool-1 
  CIP-1 NaOH(2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-17/AF104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation: Ferment-1 in P-16/DBS-104 
P-21/DC-101 Centrifuge-1 Equipment based on Solids Removal Relative to end of Transfer-Out-1 in P16 
   Solids Concentration in Stream = 1000g/L   
  SIP-1 (steam in place) Default Settings   
      
P-30/ ST-101 Sterilize-1 Default Settings Relative to end of Centrifuge-1 in P-21 
      
P-20/ FDR-
101 Transfer-In-1 Default Settings Relative to end of Centrifuge-1 in P-21 
  Dry-1 Final LOD = 0.01 Relative to end of Transfer-In-1 
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Table 22 Continued 3 
   FBS, Lactic Acid and Water set to be volatile   
 Transfer-Out-1 100% of vessel contents Relative to end of Dry-1 
    
 CIP-1 Uses NaOH (2M)  
  SIP-1 Default Settings Relative to end of CIP-1 
      
      
     
P-22/NM-
101 Nano-Mill-1 Default Settings Relative to End of Transfer-Out-1 in P-20 
  CIP-1 Default Settings   
  SIP-1 Default Settings Relative to End of CIP 
      
P-23/V-106 Charge-1 Mass = 5 kg Relative to Start of Nano-Mill-1 in P22 
  Charge-3 Mass = 20 kg Relative to end of Charge-1 
  Charge-2 Mass = 5 kg Relative to end of Charge-3 
  Transfer-In-1 Default settings Relative to end of Charge-2 
  Agitate-1 Default settings Relative to end of Transfer-In-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default settings Relative to end of Transfer-Out-1 
      
P-24/GRN-
101 Granulate-1 Water is volatile, 5% Final LOD Relative to end of Transfer-Out-1 in P23 
  SIP-1 Default Settings Relative to end of Granulate-1 
      
P-25/V-107 Transfer-In-1 Default Settings Relative to end of Granulate-1 in P24 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  Transfer-Out-1 100% of vessel contents Relative to end of Store-1 
      
P-26/TP-101 Tablet-1 Default Settings Relative to end of Transfer-Out-1 in P25 
  CIP-1 NaOH (2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-27/DB-101 Transfer-In-1 Default Settings Relative to end of Tablet-1 in P26 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  Transfer-Out-1 Default Settings Relative to end of Store-1 
      
P-29/V-108 Charge-1 Mass = 48 kg Relative to end of Tablet-1 in P26 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Pull-Out Set by Mast-Slave Relationship Relative to start of Coat-1 in P-28 
   Operation: Coat-1 in P28   
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P-28 Transfer-In-1 Default Settings Relative to end of Transfer-Out-1 in P27 
  Coat-1 Default Settings; 4 cycles Relative to end of Transfer-In 




























Table 23 Model 4 Disposable Info 
Label Operations Changes to Default Scheduling Start Times 
P-3/V-101* Charge-1 V = 2000 L Relative to Beginning of Batch 
  Agitate-1 Default Settings Relative to end of Charge-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default Settings Relative to end of Transfer-Out-1 
      
P-5/DE-101 Filter-1 Default Settings Relative to end of Transfer-Out-1 
      
P-4/V-102* Transfer-In-1 Default Settings Relative to Beginning of Batch 
  
Transfer-Out-
1  Set Volume = 20 mL Relative to end of Transfer-In-1 
  Store-1 Set by Master-Slave Relationship Relative to end of Transfer-Out-1 
   Operation Ferment-1 in P-1   
  
Transfer-Out-
2 Set Volume = 200 mL Relative to end of Ferment-1 in P-1 
  Store-2 Set by Master-Slave Relationship Relative to end of Transfer-Out-2 
   Operation Ferment-1 in P-2   
  
Transfer-Out-
3 Set Volume = 4 L Relative to end of Store-2 
  Store-3 Set by Master-Slave Relationship Relative to end of Transfer-Out-3 
   Operation Ferment-1 in P-6   
  
Transfer-Out-
4 Set Volume = 80 L Relative to end of Ferment-1 in P-7 
  Store-4 Set by Master-Slave Relationship Relative to end of Transfer-Out-4 
   Operation Ferment-1 in P-8   
  
Transfer-Out-
5 Set Volume = 1600L Relative to end of Store-4 
  SIP Default Settings Relative to end of Transfer-Out-5 
      
P-1/TRF-101 Transfer-In-1 Default Settings Relative to Beginning of Batch 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Charge-1 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1 
      
P-2/ DBS-101 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1 
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Table 23 Continued 1 
P-12/ AF-101 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-2 
P-6/ DBS-102 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-2 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
      
P-13/AF-102 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-6 
P-8/ DBS-104 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-6 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
      
P-14/ AF-103 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-8 
P-7/ DBS-103 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-8 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
      
P-15/AF-104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-7 
P-9/DS-101 Centrifuge-1 Solids Removal Relative to end of Transfer-Out in P-7 
   Solids Concentration = 1000 g/L   
  SIP-1 Default Settings Relative to end of Centrifuge-1 
      
P-16/ ST-101 Sterilize-1 Default Settings Relative to end of Centrifuge-1 in P-9 
      
P-10/ FDR-
101 Dry-1 Final LOD = 0.01% Relative to end of Centrifuge-1 in P-9 
   FBS Media, Lactic Acid and Water    
   are volatile   
  SIP-1 Default settings Relative to end of Dry-1 
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Table 23 Continued 2 
P-11/ NM-
101 Nano-Mill-1 Default Settings Relative to end of Dry-1 in P-10 
  SIP-1 Default Settings Relative to end of Nano-Mill-1 
      
P-23/V-106 Charge-1 Mass = 5 kg Relative to Start of Nano-Mill-1 in P-11 
  Charge-3 Mass = 20 kg Relative to end of Charge-1 
  Charge-2 Mass = 5 kg Relative to end of Charge-3 
  Transfer-In-1 Default settings Relative to end of Charge-2 
  Agitate-1 Default settings Relative to end of Transfer-In-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default settings Relative to end of Transfer-Out-1 
      
P-24/GRN-
101 Granulate-1 Water is volatile, 5% Final LOD 
Relative to end of Transfer-Out-1 in 
P23 
  SIP Default Settings Relative to end of Granulate-1 
      
P-25/V-107 Transfer-In-1 Default Settings Relative to end of Granulate-1 in P24 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Store-1 
      
P-26/TP-101 Tablet-1 Default Settings 
Relative to end of Transfer-Out-1 in 
P25 
  CIP-1 NaOH (2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-27/DB-101 Transfer-In-1 Default Settings Relative to end of Tablet-1 in P26 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  
Transfer-Out-
1 Default Settings Relative to end of Store-1 
      
P-29/V-108 Charge-1 Mass = 48 kg Relative to end of Tablet-1 in P26 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Pull-Out Set by Mast-Slave Relationship Relative to start of Coat-1 in P-28 
   Operation: Coat-1 in P28   
      
P-28 Transfer-In-1 Default Settings 
Relative to end of Transfer-Out-1 in 
P27 
  Coat-1 Default Settings; 4 cycles Relative to end of Transfer-In 
  
Transfer-Out-




Table 24 Model 4 50/50 Info 
Label Operations Changes to Default Scheduling Start Times 
P-3/V-101* Charge-1 V = 2000 L Relative to Beginning of Batch 
  Agitate-1 Default Settings Relative to end of Charge-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default Settings Relative to end of Transfer-Out-1 
      
P-5/DE-101 Filter-1 Default Settings Relative to end of Transfer-Out-1 
      
P-4/V-102* Transfer-In-1 Default Settings Relative to Beginning of Batch 
  
Transfer-Out-
1  Set Volume = 20 mL Relative to end of Transfer-In-1 
  Store-1 Set by Master-Slave Relationship Relative to end of Transfer-Out-1 
   Operation Ferment-1 in P-1   
  
Transfer-Out-
2 Set Volume = 200 mL Relative to end of Ferment-1 in P-1 
  Store-2 Set by Master-Slave Relationship Relative to end of Transfer-Out-2 
   Operation Ferment-1 in P-2   
  
Transfer-Out-
3 Set Volume = 4 L Relative to end of Store-2 
  Store-3 Set by Master-Slave Relationship Relative to end of Transfer-Out-3 
   Operation Ferment-1 in P-6   
  
Transfer-Out-
4 Set Volume = 80 L Relative to end of Ferment-1 in P-7 
  Store-4 Set by Master-Slave Relationship Relative to end of Transfer-Out-4 
   Operation Ferment-1 in P-8   
  
Transfer-Out-
5 Set Volume = 1600L Relative to end of Store-4 
  SIP Default Settings Relative to end of Transfer-Out-5 
      
P-1/TRF-101 Transfer-In-1 Default Settings Relative to Beginning of Batch 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Charge-1 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1 
      
P-2/ DBS-101 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1 
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Table 24 Continued 1 
  CIP-1 NaOH (2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-12/ AF-101 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-2 
P-6/ DBS-102 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-2 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
  CIP-1 NaOH (2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-13/AF-102 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-6 
P-8/ DBS-104 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-6 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
      
P-14/ AF-103 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-8 
P-7/ DBS-103 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-8 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
      
P-15/AF-104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-7 
P-9/DS-101 Centrifuge-1 Solids Removal Relative to end of Transfer-Out in P-7 
   Solids Concentration = 1000 g/L   
  SIP-1 Default Settings Relative to end of Centrifuge-1 
      





Table 24 Continued 2 
P-10/ FDR-
101 Dry-1 Final LOD = 0.01% Relative to end of Centrifuge-1 in P-9 
   FBS Media, Lactic Acid and Water    
   are volatile   
  SIP-1 Default settings Relative to end of Dry-1 
      
P-11/ NM-
101 Nano-Mill-1 Default Settings Relative to end of Dry-1 in P-10 
  SIP-1 Default Settings Relative to end of Nano-Mill-1 
      
P-23/V-106 Charge-1 Mass = 5 kg Relative to Start of Nano-Mill-1 in P-11 
  Charge-3 Mass = 20 kg Relative to end of Charge-1 
  Charge-2 Mass = 5 kg Relative to end of Charge-3 
  Transfer-In-1 Default settings Relative to end of Charge-2 
  Agitate-1 Default settings Relative to end of Transfer-In-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default settings Relative to end of Transfer-Out-1 
      
P-24/GRN-
101 Granulate-1 Water is volatile, 5% Final LOD Relative to end of Transfer-Out-1 in P23 
  SIP Default Settings Relative to end of Granulate-1 
      
P-25/V-107 Transfer-In-1 Default Settings Relative to end of Granulate-1 in P24 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Store-1 
      
P-26/TP-101 Tablet-1 Default Settings Relative to end of Transfer-Out-1 in P25 
  CIP-1 NaOH (2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-27/DB-101 Transfer-In-1 Default Settings Relative to end of Tablet-1 in P26 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  
Transfer-Out-







Table 24 Continued 3 
P-29/V-108 Charge-1 Mass = 48 kg Relative to end of Tablet-1 in P26 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Pull-Out Set by Mast-Slave Relationship Relative to start of Coat-1 in P-28 
   Operation: Coat-1 in P28   
      
P-28 Transfer-In-1 Default Settings Relative to end of Transfer-Out-1 in P27 
  Coat-1 Default Settings; 4 cycles Relative to end of Transfer-In 
  
Transfer-Out-

























Table 25 Model 4 Reusable Info 
Label Operations Changes to Default Scheduling Start Times 
P-3/V-101* Charge-1 V = 2000 L Relative to Beginning of Batch 
  Agitate-1 Default Settings Relative to end of Charge-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default Settings Relative to end of Transfer-Out-1 
      
P-5/DE-101 Filter-1 Default Settings Relative to end of Transfer-Out-1 
      
P-4/V-102* Transfer-In-1 Default Settings Relative to Beginning of Batch 
  
Transfer-Out-
1  Set Volume = 20 mL Relative to end of Transfer-In-1 
  Store-1 Set by Master-Slave Relationship Relative to end of Transfer-Out-1 
   Operation Ferment-1 in P-1   
  
Transfer-Out-
2 Set Volume = 200 mL Relative to end of Ferment-1 in P-1 
  Store-2 Set by Master-Slave Relationship Relative to end of Transfer-Out-2 
   Operation Ferment-1 in P-2   
  
Transfer-Out-
3 Set Volume = 4 L Relative to end of Store-2 
  Store-3 Set by Master-Slave Relationship Relative to end of Transfer-Out-3 
   Operation Ferment-1 in P-6   
  
Transfer-Out-
4 Set Volume = 80 L Relative to end of Ferment-1 in P-7 
  Store-4 Set by Master-Slave Relationship Relative to end of Transfer-Out-4 
   Operation Ferment-1 in P-8   
  
Transfer-Out-
5 Set Volume = 1600L Relative to end of Store-4 
  SIP Default Settings Relative to end of Transfer-Out-5 
      
P-1/TRF-101 Transfer-In-1 Default Settings Relative to Beginning of Batch 
  Charge-1 Volume = 5 mL Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Charge-1 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1 
      
P-2/ DBS-101 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P1 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1 
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Table 25 Continued 1 
  CIP-1 NaOH (2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-12/ AF-101 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-2 
P-6/ DBS-102 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-2 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
  CIP-1 NaOH (2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-13/AF-102 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-6 
P-8/ DBS-104 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-6 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
  CIP-1 NaOH (2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-14/ AF-103 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-8 
P-7/ DBS-103 Transfer-In-1 Default Settings Relative to end of Ferment-1 in P-8 
  Transfer-In-2 Default Settings Relative to end of Transfer-In-1 
  Ferment-1 Final Temp = 28° C Relative to end of Transfer-In-2 
   Time = 8days   
  
Transfer-Out-
1 100% of vessel contents Relative to end of Ferment-1  
  CIP-1 NaOH (2M)   
   Waste Disposal = $50 per kg   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-15/AF-104 Filter-1 Default Settings Set by Master-Slave Relationship 
    Operation Ferment-1 in P-7 
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Table 25 Continued 2 
P-9/DS-101 Centrifuge-1 Solids Removal Relative to end of Transfer-Out in P-7 
   Solids Concentration = 1000 g/L   
  SIP-1 Default Settings Relative to end of Centrifuge-1 
      
P-16/ ST-101 Sterilize-1 Default Settings Relative to end of Centrifuge-1 in P-9 
      
P-10/ FDR-
101 Dry-1 Final LOD = 0.01% Relative to end of Centrifuge-1 in P-9 
   FBS Media, Lactic Acid and Water    
   are volatile   
  SIP-1 Default settings Relative to end of Dry-1 
      
P-11/ NM-
101 Nano-Mill-1 Default Settings Relative to end of Dry-1 in P-10 
  SIP-1 Default Settings Relative to end of Nano-Mill-1 
      
P-23/V-106 Charge-1 Mass = 5 kg Relative to Start of Nano-Mill-1 in P-11 
  Charge-3 Mass = 20 kg Relative to end of Charge-1 
  Charge-2 Mass = 5 kg Relative to end of Charge-3 
  Transfer-In-1 Default settings Relative to end of Charge-2 
  Agitate-1 Default settings Relative to end of Transfer-In-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Agitate-1 
  SIP-1 Default settings Relative to end of Transfer-Out-1 
      
P-24/GRN-
101 Granulate-1 Water is volatile, 5% Final LOD Relative to end of Transfer-Out-1 in P23 
  SIP Default Settings Relative to end of Granulate-1 
      
P-25/V-107 Transfer-In-1 Default Settings Relative to end of Granulate-1 in P24 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  
Transfer-Out-
1 100% of vessel contents Relative to end of Store-1 
      
P-26/TP-101 Tablet-1 Default Settings Relative to end of Transfer-Out-1 in P25 
  CIP-1 NaOH (2M)   
  SIP-1 Default Settings Relative to end of CIP-1 
      
P-27/DB-101 Transfer-In-1 Default Settings Relative to end of Tablet-1 in P26 
  Store-1 Default Settings Relative to end of Transfer-In-1 
  
Transfer-Out-





Table 25 Continued 3 
P-29/V-108 Charge-1 Mass = 48 kg Relative to end of Tablet-1 in P26 
  Agitate-1 Default Settings Relative to end of Charge-1 
  Pull-Out Set by Mast-Slave Relationship Relative to start of Coat-1 in P-28 
   Operation: Coat-1 in P28   
      
P-28 Transfer-In-1 Default Settings Relative to end of Transfer-Out-1 in P27 
  Coat-1 Default Settings; 4 cycles Relative to end of Transfer-In 
  
Transfer-Out-
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